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Abstract 
Implementation of an Advance Care Planning Discussion for Patients with Chronic 
Kidney Disease 
Chelsea Hinders 
2017 
 
Clinical practice guidelines (CPGs) support the need for providers to engage patients in a 
discussion of goals and priorities regarding end-of-life care through the use of advance 
care planning (ACP) (Agency for Healthcare Research and Quality [AHRQ], 2014).  
However, current data demonstrated a lack of implementation specific to patients with 
chronic kidney disease (CKD).  A five question standardized tool developed from current 
guidelines served as the discussion guide for this intervention.  Despite the great need for 
this project, patients who were eligible for the intervention were not willing to be active 
participants in an ACP discussion.  The clinical significance, most notably the increased 
awareness of the nephrology Nurse Practitioner (NP) and other clinic providers, 
demonstrated ACP can be successful.  Further research is needed to transform the topic 
of ACP in both research and practice.      
 Keywords: advance care planning, advance directive, chronic kidney disease  
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Chapter 1 
Introduction 
Introduction 
 The kidneys are a paired organ system that filter, reabsorb, and excrete solutes, 
water, and harmful toxins from the body.  Fluids, electrolytes, and acid-base balance are 
closely regulated by this organ system as well as the production of vitamin D and 
erythropoietin (Chisholm-Burns et al., 2013).  When part or all of these functions are lost 
for a time period of greater than three months, chronic kidney disease (CKD) develops.  
Those who are plagued with CKD experience a progressive loss of kidney function that 
can occur over months to years.  This decline is often irreversible and may result in end-
stage renal disease (ESRD) at which point dialysis or another form of renal replacement 
therapy may be required (Chisholm-Burns et al., 2013).         
 A large number of individuals may be unaware they are living with CKD making 
it challenging to successfully treat this condition.  In addition, patients with CKD are 
older, usually have multiple comorbid conditions, and face death earlier than the average 
individual (Wasylynuk & Davison, 2015).  This raises the need for advance care planning 
(ACP) in this patient population.  Defined more thoroughly, ACP is a process involving 
reflection, discussion, and structured communication between a patient, family member, 
caregiver, close friend, and/or a health care provider that helps to clarify an individual’s 
health status, prognosis, values, goals, and treatment preferences for end-of-life care 
(Davison, 2012).  However, ACP is not part of the routine care of patients with CKD, 
despite the chronic and debilitating nature of the condition (Wasylynuk & Davison, 
2015).   
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Significance of the Problem 
CKD exists along a continuum of stages one to five based on glomerular filtration 
rate (GFR).  Kidney damage is present at stage two and ESRD exists at stage five 
(Chisholm-Burns et al., 2013).  Today, CKD plagues nearly 26 million Americans and 
millions of others may be at risk for this diagnosis (National Kidney Foundation, 2016).  
Five years ago, one in 10 American adults was living with some form of CKD (U.S. 
Department of Health and Human Services, National Institutes of Health [NIH], 2012).  
In addition, the incidence of CKD was greatest among those 65 years of age and older, 
with this rate more than doubling between 2000 and 2008 (NIH, 2012).  Alarmingly, 
these numbers continued to grow by about 10% per year (Harrison & Watson, 2011). 
Mortality is much higher in those with ESRD than in the general population.  In 
2009, the number of deaths from ESRD totaled over 90,000, as compared to just over 
10,000 in 1980 (NIH, 2012).  Patients who were referred to a nephrologist or who started 
dialysis later in the disease process had significantly poorer survival rates and were at risk 
for an earlier death as compared to their healthier counterparts.  The later stages of CKD, 
such as stages four and five, are often accompanied by a less than optimal health state, 
less residual kidney function, and longer periods of acute hospitalizations (Wasylynuk & 
Davison, 2015).   
Failure to establish an individual’s own goals of care, such as what occurs during 
ACP, often resulted in unnecessary admissions to the hospital, invasive procedures, and 
more aggressive care than individually desired for patients with CKD (Davison, 2012).  
CKD may seem like an easy disease to control and manage, but an individual’s CKD 
progression is largely unpredictable and no definitive prognosis can be effectively made 
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(Wasylynuk & Davison, 2015).  These facts together stress the need for an early 
discussion about a patient’s wants, goals, and desires should they near the end-of-life 
quicker than imagined.      
Those without an advance directive (AD) lack specific goals of care for their end-
of-life.  In a time of a health crisis, those nearest to the patient, such as family members, 
close friends, or even health care providers, must make decisions regarding a patient’s 
treatment.  This can result in unnecessary stress for these persons and uncertainty in their 
decision making since a discussion about what should and should not be done in this 
situation has never been discussed with the patient.  These treatments can go against what 
the patients would want for themselves without an exact document stating their wishes.  
The end result may hover between two ends of the spectrum, prolonging life 
unnecessarily or allowing patients to die despite their desire to continue with aggressive 
treatment.  However, a successfully implemented ACP discussion allows patients to 
enjoy their last few days giving them time to reflect on their prior life experiences with 
self-worth.  Having a developed AD prior to experiencing a health crisis or the end-of-
life often ensures these crucial matters have been voiced with those closest to them.  
The concept of ACP focuses on the early identification of individual needs, wants, 
and desires should a patient become incapable of making his or her own decisions.  It 
involves naming a surrogate decision maker, discussing individual goals of care with 
family members, close friends, or health care providers, and making critical decisions as 
to what is desired at or near the end-of-life (Wasylynuk & Davison, 2015).  The 
development of an advance care plan is often a continuous process, revisited by the 
patient, family member, and health care provider at many successive visits once the 
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initial topic had been brought forth (Davison, 2012).  Widespread use of ACP enhances 
communication between patients and providers, improves quality of life for patients and 
family members, reduces unnecessary and unwanted hospitalizations, and decreases 
health care costs (Rietjens et al., 2016).  Nicholas, Langa, Iwashyna, and Weir’s (2011) 
study showed Medicare beneficiaries with treatment-limiting ADs spent up to $380,200 
on end-of-life care as compared to those without ADs, whose costs were $522,754.  Life-
sustaining treatment differences between the two groups were statistically significant for 
those with an AD using less than half of the resources required by those without an AD 
(Nicholas et al., 2011).  While the necessity of ACP has been stressed in multiple 
settings, this work flow continues to be underutilized today, despite a great patient desire 
to partake in these conversations (Goff et al., 2015).   
Those who reported previously using ACP described increased control over 
medical situations, relief of burdens on loved ones, and strengthened relationships with 
family members (Holley, 2012).  However, specifically for patients with CKD, nearly 
half of all patients living with ESRD have some form of cognitive impairment and are 
unable to participate in decision making at the end-of-life (Feely et al., 2016).  Moderate 
to severe cognitive impairment was common in over 70% of dialysis patients, despite 
having no history of former changes in mental status (Davison, 2012).  This change is 
thought to occur due to blood vessel disease and resulting hypoperfusion, or decrease in 
blood flow, to the brain cells.  Brain imaging of these patients commonly showed areas of 
damaged tissue and an increased risk of stroke due to this decrease in blood flow 
(Tamura & Yaffe, 2011).  In addition, depression was common and often unrecognized 
among those with CKD, both before and during dialysis therapy (Davison, 2012).  Death, 
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hospitalization, and disability rates were higher among those with this condition in 
conjunction with CKD (Tamura & Yaffe, 2011).  The above issues contribute negatively 
to ACP and hinder a patient’s ability to actively participate in end-of-life decision making 
once the disease has progressed.  These psychiatric conditions make it more difficult to 
formulate an advance care plan or AD document with this patient population.   
ACP is a fluid process, not a single act, that should first occur with the patient and 
his or her family members.  One of the most beneficial times for ACP to occur in patients 
with CKD is when dialysis or other conservative options are first presented to the patient 
and/or family members.  After this topic is first presented to the patient, it is then brought 
up at successive office visits and is revisited on a regular basis to ensure the patient’s care 
plan remains consistent with one’s wants, goals, and desires for their end-of-life care 
(Davison, 2012).  ACP focuses on an individual’s broad goals of care and helps serve as a 
facilitator of discussion among patients, families, and health care providers.  In this 
population, specific goals to be addressed through ACP include the decision to start or 
stop dialysis or to pursue other forms of renal replacement therapy.  However, a lack of 
knowledge of the ACP process among this patient population is a major barrier to its 
current use.     
ADs are also an important component of ACP.  In 1991, the Patient Self 
Determination Act stressed the necessity of ensuring patients enact ADs to guarantee 
their goals for end-of-life care are honored at a very critical point in their lives.  However, 
this law did little to increase the use and completion of ADs, as only 36% of the United 
States population had documented their wishes for end-of-life care in 2011 (Pecanac, 
Repenshek, Tennenbaum, & Hammes, 2014).  Encouraging patients to have these crucial 
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conversations and to engage in ACP is not only essential to good end-of-life care but 
provides patients with this chronic condition some control over one part of their lives.       
The high prevalence of CKD, its unpredictable course, and the relatively small 
number of individuals who had completed ADs or participated in the unique process of 
ACP stressed the impetus to explore this concern further through this Doctor of Nursing 
Practice (DNP) Project.  Given the compounding factors listed above, matching 
individual goals of care with the care received as the disease progresses is critical for 
patients with CKD (Goff et al., 2015).  In communication with an Advance Practice 
Registered Nurse (APRN), ACP specific to patients with CKD is not a routine and 
consistent process implemented in an urban Midwestern nephrology clinic (K. Jerke, 
personal communication, May 19, 2016).  As health care providers, the implementation 
and consistent use of ACP can result in more informed and prepared patients and family 
members.  The purpose of this DNP Project was to help patients identify their personal 
goals of care in the CKD disease process, decide for themselves what it is they want for 
their last few months, and promote a more dignified dying process.     
Population of Interest 
The population of interest included adult patients who were in CKD stages four 
and five based on GFR without an existing AD document.  GFR is defined as the amount 
of blood filtered across the capillary of the kidney, or the glomerulus, per unit time, based 
on serum creatinine level, age, sex, and race (Harrison & Watson, 2011).  A normal GFR 
is more than 90 mL/min/1.73 m2.  Age-related declines in kidney function are common; 
however, one does not normally progress to stages four and five without persistent kidney 
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damage.  Stage four CKD is defined as a GFR between 15-29 mL/min/1.73 m2 and stage 
five is a GFR less than 15 mL/min/1.73 m2 (Chisholm-Burns et al., 2013).   
Other risk factors associated with CKD include low kidney mass, low birth 
weight, being of a racial or ethnic minority, having a family history of kidney disease, 
and having a low income or low education level (Chisholm-Burns et al., 2013).  Diabetes 
is the most common cause of CKD while hypertension is a close second, especially when 
these conditions are uncontrolled.  Together, these two illnesses account for roughly two-
thirds of all cases of impaired kidney function (National Kidney Foundation, 2016).  
Other diseases, such as autoimmune diseases, polycystic kidney disease, urinary tract 
infections, and elevated cholesterol levels can all contribute to an increased incidence of 
CKD.  Often, once sustained damage has occurred to an individual’s kidneys, it is 
impossible to regain prior function (Chisholm-Burns et al., 2013).      
Patients with CKD stages four and five were chosen for the project sample due to 
the chronicity of this health condition.  Once a patient reaches these stages, kidney 
damage is irreversible and ESRD is most likely to result.  A thorough discussion of 
dialysis and other forms of renal replacement therapy takes place between the patient and 
health care provider once a patient reaches these advanced stages of kidney disease.  An 
individual’s prognosis and the limited treatment options can be addressed with ACP.  
Informed health care consumers can make more realistic choices and will have the 
potential to experience a quality of life they are satisfied with, even with a diagnosis of an 
incurable health care condition.     
 A large group of patients are likely to benefit from the implementation of ACP.  
This includes patients with CKD who have decided to manage their health conservatively 
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without dialysis or other forms of renal replacement therapy, those whom a trained health 
care provider knows have a poor prognosis or are near death, and those who are 
considering withdrawing from dialysis therapy.  Patients who have difficulty determining 
simple goals of care, those who have experienced great functional decline within the last 
year, and those who have experienced an acute change in health, such as a debilitating 
stroke or heart attack, may also be appropriate for a structured use of ACP (Davison, 
2012).  However, it is essential to understand that any patient with CKD can benefit from 
the process of ACP.  As it has been developed today, ACP can and should be used with 
any patient at any time.   
Clinical Question  
 The clinical question for this DNP Project was asked in PICOT format.  P stands 
for patient population, I stands for intervention, C stands for comparison intervention, O 
stands for outcome, and T stands for time frame (Melnyk & Fineout-Overholt, 2011).   
 (P) In adult patients with CKD stages four and five in an urban Midwestern 
nephrology clinic, does (I) implementation of an ACP discussion (C) compared to usual 
care (O) increase patient knowledge of ACP and increase completion of ADs (T) over a 
three month time period?    
 For the last six years, the DNP Project coordinator’s clinical practice has focused 
on the care of patients with CKD.  Oftentimes, it was stressful health situations, 
unexpected illnesses, or tragic situations that triggered ACP to occur in patients of this 
type.  These patients failed to acknowledge the extent of their situation and refused to 
prepare for their final days.  Family members routinely felt unprepared to make these 
difficult decisions and were often uncertain about what it was the patient desired.  
ADVANCE CARE PLANNING                                                                                      9 
  
Desperate measures, such as ventilator support, use of feeding tubes, and long surgical 
procedures were initiated and death became a painful process for all involved, including 
the health care providers and staff caring for these patients.  A gap existed in a patient’s 
knowledge of preparing for the end-of-life and actually partaking in these processes.  
This DNP Project hoped to enable ACP to become an integral part of the care of patients 
with CKD and as such, allowed each patient to achieve his or her goals and desires at the 
end-of-life.   
Purpose of the Project 
 The purpose of this DNP Project was to implement a standardized process of ACP 
specific to patients with CKD stages four and five in an urban Midwestern nephrology 
clinic.  The usual care in this setting was while rooming a patient, the nursing staff asked 
the patient if he or she had an AD document completed.  If the patient did not, he or she 
was then asked if he or she would like information on completing one.  Information on 
forming an advance care plan was sometimes provided but it was not specific to the care 
of patients with CKD.  No further steps were identified in regards to ACP or the 
completion of ADs.  The usual care was replaced with an ACP process specific to 
patients with CKD.  Implementation of this intervention aimed to introduce patients to 
the process of ACP and enabled eligible patients to see the necessity of an ACP 
discussion.  It was a goal of this project to increase patient knowledge of the process of 
ACP after the completion of the intervention.  In addition, patients would be enabled to 
complete an AD document and it was the desire that they would be more easily able to 
state their wishes for their end-of-life care with their family members and health care 
providers after participating in this consistent ACP intervention.   
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This project aimed to allow ACP to become a routine, dynamic practice in the 
care of all patients with CKD at this outpatient clinic.  Over time, it is the goal that 
patients will experience a greater quality of life at the end-of-life, patient wishes will be 
more easily honored at the end-of-life with the use of and increase in the completion of 
AD documents, and family members can be assured they are following their loved ones 
wishes as he or she approaches the end-of-life.  In addition, health care costs may 
decrease as patients who partake in ACP often choose less life-sustaining treatment 
measures and experience fewer unnecessary hospitalizations at the end-of-life (Rietjens et 
al., 2016).   
Definitions 
Adult – a person who is fully grown or of age 
Advance care planning (ACP) – a crucial process of thought and 
communication in which a cognitively sound person makes future health and/or personal 
care decisions in the event that they become incapable of making these decisions 
(Wasylynuk & Davison, 2015).  Advance care planning is a continuous process that 
occurs over many office visits and should be revisited with the patient on a regular basis 
(Davison, 2012). 
Advance directive (AD) – a document prepared by a competent adult that 
provides views, wishes, and directions on the steps to be taken on matters pertaining to 
health and medical treatment at a time when an individual is unable to make those 
decisions (Pandya, 2015).  These tangible documents are sometimes referred to as written 
instructional directives.  ADs are a distinct part of the process of ACP (White et al., 
2014).   
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Chronic kidney disease (CKD), also known as chronic renal insufficiency or 
progressive kidney disease – presence of kidney damage that is present for a time period 
of three months or more and is generally a progressive, irreversible loss of kidney 
function.  CKD exists along a continuum of stages from one to five.  Kidney damage 
exists at stage two and dialysis typically begins at stage five (Chisholm-Burns et al., 
2013).   
Do-not-resuscitate (DNR), also known as a no code – a medical term that 
allows a patient to die naturally.  Often used for a patient who has a terminal or chronic 
health condition.  When a patient’s heart stops beating or a patient stops breathing, no 
unnecessary or life-sustaining measures are undertaken to prolong the patient’s life 
(Santonocito, Ristagno, Gullo, & Weil, 2013).   
End stage renal disease (ESRD), which is also known as CKD stage five – an 
individual’s GFR is below 15 mL/min/1.73 m2 and dialysis or another form of renal 
replacement therapy may be required to sustain life (Chisholm-Burns et al., 2013). 
Glomerular filtration rate (GFR) – the amount of blood filtered across the 
capillary of the kidney, or the glomerulus, per unit time, based on serum creatinine level, 
age, sex, and race (Harrison & Watson, 2011).  A normal GFR is more than 90 
mL/min/1.73 m2 (Chisholm-Burns et al., 2013).   
Nephrologist – a health care provider who studies and deals with the anatomy, 
management, physiology, and pathology of the kidneys (Nephrology, n.d.).  
Renal replacement therapy – a type of medical therapy that takes the place of 
the normal function of the kidneys.  Hemodialysis, peritoneal dialysis, and kidney 
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transplantation are the three known types of renal replacement therapy (Chisholm-Burns 
et al., 2013).   
Surrogate decision maker – an individual entrusted to make health care 
decisions on a person’s behalf if they are unable to do so.  This person should have the 
most knowledge about what a person does and does not want in regards to his or her 
health and end-of-life care (Wasylynuk & Davison, 2016).  
 Usual care – asking a patient if he or she has an AD document completed.  If not, 
the patient is then asked if he or she would like information on one.  Information on 
forming an advance care plan is sometimes provided, but it is not specific to the care of 
patients with CKD.  No further steps are identified in regards to ACP or the completion 
of ADs.   
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Chapter 2 
Literature Review 
Introduction  
Current clinical practice guidelines (CPGs) supported the need for providers to 
engage patients in a discussion of goals, preferences, and priorities regarding end-of-life 
care through the use of ACP (Agency for Healthcare Research and Quality [AHRQ], 
2014).  Even in those with CKD, ACP should be targeted to address specific issues that 
occur throughout the course of the disease, including initiating, withdrawing, or 
withholding dialysis therapy (Renal Physicians Association & American Society of 
Nephrology, 1999; AHRQ, 2015).  A review of the literature also supported the need for 
this intervention as a routine process in the care of all patients with CKD.  However, 
current data demonstrated a lack of implementation specific to those with this condition 
despite the known benefits for all involved.       
A literature review was conducted using the Cochrane Library, CINAHL, 
EBSCOhost, MEDLINE/PubMed, and Ovid.  Search terms included: advance care 
planning, advance directive, chronic kidney disease, culture, dialysis, end-stage renal 
disease, kidney failure, Native American, renal, and renal insufficiency.  Databases were 
searched from the years 2011 to 2016.  The United States Preventive Services Task Force 
(USPSTF) and the Agency for Healthcare Research and Quality (AHRQ) were searched 
for relevant CPGs.  Search terms included: advance care planning, chronic, dialysis, and 
renal.  Relevant guidelines were searched from the years 2011 to 2016.   
Inclusion criteria for the research studies and CPGs for this literature review 
included peer-reviewed articles, written in the English language, consisted of patients 18 
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years of age and older, and involved an ACP intervention to determine the effect on 
patient and family outcomes and/or the completion of ADs.  Articles and CPGs were 
excluded if they studied the effects of an intervention targeted to health care providers or 
persons younger than the age of 18, utilized a computer-based intervention, were a study 
protocol, and were not research based.  Together, the combined searches yielded 568 
articles that was limited to 20 documents based on the specific exclusion criteria that 
answered the PICOT question listed above.  Appendix F lists the literature review 
methods table.     
All retained articles were appraised using the John Hopkins Research Evidence 
Appraisal Tool (Dearholt & Dang, 2012).  This model assigns a level of evidence, level I 
– V, to each article based on study design.  The level of evidence assigned to an article is 
synonymous with the strength of the article.  The highest level of evidence, level I 
articles, include randomized controlled trials (RCT) and systematic reviews of RCTs, 
both with and without meta-analyses.  Level II evidence consists of quasi-experimental 
studies.  Next, level III is composed of non-experimental studies and qualitative studies.  
Level IV contains expert opinion included in CPGs and consensus panels.  Finally, level 
V is literature reviews, quality improvement projects, and case reports (Dearholt & Dang, 
2012). 
The John Hopkins Research Evidence Appraisal Tool also assigns each article a 
quality grade, in letters A – C (Dearholt & Dang, 2012).  Grade A articles are of the 
highest quality and contain consistent and generalizable results, a sufficient sample size 
for the study design, adequate control, definite conclusions, and consistent 
recommendations.  Grade B articles, good quality, are defined by reasonably consistent 
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results, sufficient sample size based on study design, some level of control, fairly definite 
conclusions, and reasonably consistent recommendations.  Finally, grade C articles, low 
or major flaw, consist of little evidence with inconsistent results, insufficient sample size 
for the study design, and no definitive conclusions (Dearholt & Dang, 2012).   
CPGs were appraised using the Agree II Instrument (Agree Enterprise, n.d.).  The 
Agree II Instrument assesses for variability in CPGs, evaluates the quality of CPGs, and 
provides a strategy for the development of these guidelines.  This tool consists of 23 
items categorized into six domains: scope and purpose, stakeholder involvement, rigour 
of development, clarity of presentation, applicability, and editorial independence.  
Finally, two assessment questions are asked of the appraiser to rate the ability to use the 
CPG in practice.  This instrument aims to greatly improve the quality of health care 
through the rigorous appraisal of CPGs (Agree Enterprise, n.d.).  An evidence table was 
developed to display the level and quality of evidence, sample, setting, participants, type 
of study design, intervention, results, strengths, and limitations (see Appendix G).           
Evidence Findings  
 This literature review focused on an ACP intervention for patients with CKD 
stages four and five.  Based on the developed PICOT question and the inclusion and 
exclusion criteria listed above, outcomes desired included an increase in knowledge of 
the ACP process, an increase in ACP discussions with patients and family 
members/caregivers, and an increase in the frequency of AD completion.  Literature 
found focused largely on qualitative and descriptive outcomes with this population, 
which strengthened the need for both a quantitative and qualitative focus for this DNP 
Project.   
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The 20 chosen studies were reviewed and critically appraised to determine the 
level of evidence.  The John Hopkins Research Evidence Appraisal Tool classified the 
articles as three in level I, three in level II, 11 in level III, two in level IV, and one in 
level V.  Two studies were appraised as low quality or C evidence.  One of these studies 
was included due to the nature of the study design (quasi-experimental) and the lack of 
the availability of this type of results with this topic.  This study never discussed the 
reliability and validity of the study instruments, which decreased the potential quality of 
the findings (Kirchhoff, Hammes, Kehl, Briggs, & Brown, 2012).  The second article was 
included due to the type of study group and the ability to show the benefit of ACP in a 
number of different patient populations (Colombian, Mexican, and Puerto Rican women) 
(Carrion, Nedjat-Haiem, Martinez-Tyson, & Casteñeda, 2013). 
Two CPGs were appraised using the Agree II Instrument.  Based on the results, 
both were of high quality, 4/7 and 5/7 respectively, and were appropriate for use in 
practice (Renal Physicians Association & American Society of Nephrology, 1999; 
AHRQ, 2014; AHRQ, 2015).  One of the original CPGs found for this project was 
developed in 1999 by the Renal Physicians Association and the American Society of 
Nephrology.  This document has subsequently been updated in 2010 and re-affirmed for 
practice in 2013.  Both documents were used in this literature review and throughout the 
DNP Project (Renal Physicians Association & American Society of Nephrology, 1999; 
AHRQ, 2015).  The specific findings are grouped and synthesized below.  
 Efficacy of ACP.  The AHRQ CPG (2014) recommended using a structured ACP 
process in patients with conditions for which death within the next year would not be 
unlikely, any patient with a chronic illness, and any patient over the age of 55.  It is easy 
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to see that a patient with CKD, the population component of the PICOT question, fits 
many of these requirements.  However, even if their death is not likely within the next 
year, ACP can and still is a beneficial process for these patients.  The findings of two 
meta-syntheses stressed the necessity of answering the developed clinical question with 
both structure and communication.  It was less important the type of intervention utilized 
but more or less that an intervention targeted to ACP took place (Luckett et al., 2014; 
Oczkowski, Chung, Havney, Mbughaw & You, 2016).  Developed CPG 
recommendations provided a valid and reliable starting point for intervention tools that 
enhanced the efficacy and use of ACP today and resulted in positive outcomes, even in 
patients with CKD (Renal Physicians Association & American Society of Nephrology, 
1999; AHRQ, 2015).   
 ACP is a process that cannot be successfully completed in one single office visit.  
White et al. (2014) stressed this concept by reinforcing that ACP was an all-
encompassing process that should consist of an ongoing conversation between a 
competent adult, his or her family, and health care professionals about one’s future goals 
of care.  Opportunities to enhance and increase the use of ACP exist at every office visit 
and should be addressed at each point of contact in the health care system.  Harrison & 
Watson (2011) implemented a nurse-led palliative care clinic that involved meetings with 
the patient and/or family members in a series of sessions over a one year time frame.  
Patients were exposed to end-of-life issues earlier in the disease process, explored fears 
about the future, and were given opportunities to make necessary decisions with their 
family or caregivers.  Family members felt more in control, had a better idea of the 
disease progression, felt more prepared for the future, and were less anxious about the 
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end-of-life process after these series of meetings (Harrison & Watson, 2011).  At the very 
least, an ACP discussion should be implemented annually with those with a chronic 
condition or when a patient transitions to the next stage of CKD (AHRQ, 2014; Bristowe 
et al., 2015; Goff et al., 2015).   
 Completion of ADs.  The AHRQ (2014) encouraged all patients to complete an 
AD.  The dialysis center setting was an appropriate time and place to participate in an 
ACP discussion in patients who received hemodialysis.  Those who participated generally 
did not see any problems completing these end-of-life documents and were more willing 
to do so and to participate in a palliative medicine consultation if needed after an ACP 
discussion (Amro, Ramasamy, Strom, Weiner, & Jaber, 2016; Felly et al., 2016).   
When searching to determine what would be best to answer the PICOT question, 
the type of ACP intervention did not matter.  The use of structure, communication, and 
actual implementation of ACP resulted in positive outcomes.  Completion of ADs was 
greatly increased, patients were more satisfied with their care, end-of-life care was 
congruent with their wishes, and costs were decreased at the end-of-life with the 
implementation of ACP (Nicholas et al., 2011; Luckett et al., 2014; Oczkowski et al., 
2016).  Overall care of patients with CKD will be greatly enhanced with the long-term 
and successful implementation of an ACP discussion.   
The patient population of those with CKD varies in both race and ethnicity.  It 
was important to consider the factors those other than Caucasian or Northern European 
descent may have in regards to participating in this intervention that may result in fewer 
AD documents completed.  African American patients, patients from Australia, and 
Hispanic women were less likely to want to complete an AD document.  Knowledge of 
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what these actual documents were and what an AD meant was the biggest barrier to their 
completion (Bullock, 2011; Carrion et al., 2013; White et al., 2014). 
 Patient benefits.  The over-arching purpose of this DNP Project was to provide 
patients with an avenue to discuss end-of-life goals before ever needing to make these 
critical decisions.  A simple intervention of an ACP discussion, similar to the intervention 
proposed with this project, showed an improved ability for patients to state their end-of-
life wishes, enhanced their capacity to partake in an ACP discussion, reduced patient 
conflict, provided better congruence with his or her goals of care, and allowed these 
decisions to be more easily handed over to family members (Luckett et al., 2014; Song et 
al., 2015; Oczkowski et al., 2016).  Wishes were explored earlier in life, future fears were 
put to rest, and professional support was provided in a non-threatening environment 
(Harrison & Watson, 2011).  Essentially, patients were more satisfied with the care 
received from their health care providers both during and after participating in an ACP 
discussion.  These studies support the long-term effects of this PICOT question and the 
routine use of ACP in this patient population.   
 When completed, ADs usually place a great limit on treatment preferences of the 
patient.  Advance care plans and ADs allow the patient to exactly state what he or she 
does not want at the end of his or her life.  Congruence of care, again, was another long-
range goal of this project but was one that could provide great benefit to all involved.  
Kirchhoff et al. (2012) and Amro et al. (2016) showed a large increase in the number of 
patients choosing a do-not-resuscitate (DNR) status after the implementation of an ACP 
discussion.  When patients make that choice, they are more likely to be supported as their 
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disease progresses.  ACP allowed patients to be informed and satisfied individuals with a 
written, fluid document stating their preferred goals and wishes.         
 Family/caregiver benefits.  Family and caregiver benefits were not a direct 
outcome of this PICOT question.  However, the long-range benefits of this project would 
greatly serve to benefit these populations.  A simple intervention of ACP resulted in 
family members who were more prepared and who easily transitioned through the end-of-
life process with their ill family members (Song et al., 2015).  Communication was 
enhanced with all involved, continuity of care was improved, anxiety was decreased, and 
overall knowledge of the entire process increased with the use of an ACP intervention 
(Luckett et al., 2014; Oczkowski et al., 2016).  Many of these outcomes were similar to 
patient benefits from an ACP discussion.  Even though these were not direct indicators 
that were measured through this project, it was necessary to understand how helpful this 
process can be for all involved.  The involvement of family members should be stressed 
when working with this clinical question.    
 Culture and health literacy barriers.  Both culture and health literacy are 
important factors to consider when discussing ACP.  Waite et al. (2013) showed African 
Americans were less likely to complete an AD.  African Americans are a fairly large 
population served by the outpatient clinic in this DNP Project.  It was necessary to 
understand this barrier prior to the implementation of this intervention.     
ADs are lacking throughout the world (Bullock, 2011; Kataoka-Yahior, Yancura, 
Page, & Inouye, 2011; Carrion et al., 2013; Waite et al., 2013; White et al., 2014).  The 
large number of individuals with CKD stressed the need to intervene with structured ACP 
discussions.  In addition, this project was targeted to all individuals to ensure those of 
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different races and ethnicities were included in this intervention.  Several studies focused 
on a lack of patient and provider knowledge of the ACP process as the major barrier to 
participating in this intervention throughout the world, including persons in Australia, 
Ireland, Thailand, and those of Asian Islander and Hispanic descent who were living in 
the United States (Artsanthia, Mawn, Chaiphibalsarisdi, Nityasuddhhi, & Triamchaisri, 
2011; Kataoka-Yahior et al., 2011; Carrion et al., 2013; Collins & Lehane, 2013; White 
et al., 2014).     
One’s culture affects many aspects of health care, including the illness 
experience, the response to illness, access to health care services, utilization of health 
care services, and interaction and communication with health care providers.  The Native 
American population is plagued with CKD almost twice as often as the Caucasian 
population (Walton, 2011).  Similar to other racial and ethnic minorities, cultural 
awareness is essential when caring for this population.  Family is an important aspect of 
the Native American population and this stressed the need to involve family members or 
caregivers in the ACP process.  Discovering the narrative story of the patient may also 
help further divulge into his or her illness course.  Spirituality, prayer, and the community 
are common components of health care of this population and should be integrated into 
care plans whenever possible.  Each individual is different in regards to what one wants 
and does not want at the end-of-life.  Oftentimes, it is demonstrating an open and honest 
lack of understanding of the culture that will enable the patient to express his or her 
wishes.  Walton (2011) showed increased exposure to the cultural group was the best way 
to understand one’s thoughts and feelings.  The use of prayer, spirituality, and traditional 
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health ceremonies should be encouraged with the Native American culture if at all 
possible (Walton, 2011).       
 Health literacy directly relates to the knowledge a person has of his or her disease, 
its progression, its treatment options, and the ACP process.  The health care professional 
must be aware of how much a patient does and does not understand in regards to his or 
her health and condition in order to successfully answer the PICOT question and in order 
to modify the intervention to fit each individual.  The health literacy of the sample 
population was not directly assessed in this study.  However, it was important to address 
how much each patient understood at the time of the intervention and to take the time to 
address all questions a patient had in regards to the CKD disease process.  The 
intervention tools used in this project were at a high readability level and this stressed the 
need to devote adequate time to help each patient understand the process of ACP.   
Waite et al. (2013) identified that those with a higher health literacy had higher 
rates of AD completion.  The intervention to answer this PICOT question was 
implemented on an individualized level.  A person’s health literacy was more deeply 
understood at the time of the intervention.  Using health literacy, an ACP discussion can 
be personalized to the patient’s level of knowledge if necessary.  Understanding the key 
characteristics of culture and health literacy enabled this PICOT question to be more 
deeply understood and successful conclusions to be reached.     
Health care resource utilization.  Health care costs and the admission for use of 
health care facilities were not direct outcomes that were measured with this clinical 
question.  However, a long-range goal of a structured ACP discussion and an increase in 
the number of developed ADs could result in a decrease in both of these concepts.  ADs 
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and participation in an ACP discussion, when developed and utilized appropriately, 
usually placed a limit on the care a patient desired to receive at the end-of-life.  This 
resulted in an overall decrease in health care costs, hospitalizations, and even usage of 
emergency room services (Nicholas et al., 2011; Oczkowski et al., 2016).   
 Suggestions to improve ACP.  ACP was an inconsistently used process in the 
care of all patients with a chronic health condition (Artsanthia et al., 2011; Bullock, 2011; 
Carrion et al., 2013; White et al., 2014; Bristowe et al., 2015).  An intervention targeted 
to ACP aimed to improve the usual care provided and helped to address and solve the 
developed clinical question.  Frequent outpatient appointments become the standard of 
care for patients with a chronic health condition such as CKD.  These visits allow trust to 
be developed and a relationship to be established between the patient and the health care 
provider.  A conversation initiated early on in the disease process, such as at the time of 
diagnosis, and initiated by a person the patient can speak freely with, such as a 
nephrology Nurse Practitioner (NP), resulted in the most achievable outcomes for this 
project.  A close, supportive, and trusting relationship with a health care provider was one 
of the most stressed and necessary aspects of successful ACP.  An active ACP discussion 
benefited the patient by enhancing satisfaction with the overall care provided and also 
allowed the provider to honor the patient’s wishes at the end-of-life (Bristowe et al., 
2015; Goff et al., 2015).     
Usual care of patients with CKD in this outpatient clinic did not routinely involve 
an ACP discussion.  For this reason, both patients and health care providers were 
unaware of the potential effects ACP could have for this patient population.  This alone 
may have made them unwilling to participate in this project (Artsanthia et al., 2011).  
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Knowledge deficits were a major barrier to the use of ACP, even with family members of 
patients with CKD.  Community awareness was raised and health care providers were 
trained to help focus on this necessary process by implementing an intervention focused 
on ACP (White et al., 2014).  This DNP Project firmly stressed the implementation of 
ACP in patients with CKD brought about by a trusting health care provider.             
 A standardized, validated, and reliable process of implementing ACP resulted in 
the most achievable outcomes for patients.  A well-developed CPG states five questions 
that should be asked routinely in the ACP process of all patients with CKD: 
1.  If you become unable to make decisions for yourself, whom do you want to 
make decisions for you? 
2.  If you had to choose between being kept alive as long as possible regardless of 
personal suffering or living a shorter time frame to avoid suffering and medical 
procedures such as breathing machines and feeding tubes, which would you pick? 
3.  Under what circumstances, if any, would you want to stop dialysis? 
4.  Under what circumstances, if any, would you not want to be kept alive with 
medical means such as cardiopulmonary resuscitation, a feeding tube, or 
mechanical ventilation?     
5.  Where do you prefer to die and whom do you wish to be with you when you 
die? (Renal Physicians Association & American Society of Nephrology, 1999; 
AHRQ, 2015, pp. 47) 
Evidence Summary (Recommendations for Practice)  
 One of the most common themes obtained from the literature review was an 
overall lack of knowledge of the ACP process for many cultures, ethnicities, and health 
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care diagnoses.  An increase in knowledge greatly enhanced both patient and family use 
of this service (Artsanthia et al., 2011).  Patients, and even family members, were 
generally willing to partake in ACP once offered but it must be delivered by a health care 
provider or person he or she can rely upon in a culturally competent manner (Goff et al., 
2015).  Patients with CKD stages four and five have a chronic health condition with 
obvious treatments, goals, and plans of care.  Although the literature was certainly 
lacking in regards to this specific diagnosis, the needs of these patients should be 
addressed with a structured ACP process which includes an individual trusted by the 
patient, the patient, and a family member or close friend.   
In summary, an ACP process specific to this group of patients with CKD is 
necessary to address their end-of-life goals, future decisions, and health-related issues 
consistent with this condition.  ACP should be a routine process in the care of all patients 
with CKD.  Finally, ACP should involve a family member or trusting individual and be 
communicated with a health care provider.    
Gaps in the Evidence  
Several gaps were identified in this literature search despite the above research 
findings.  First and foremost, a tool used during implementation of an ACP discussion 
was very difficult to find.  Many studies discussed an intervention was utilized but never 
provided a means of re-producing their study.  This literature review was unsuccessful in 
finding any specific intervention tools or project protocols that could have been used as 
the basis for or as a guide to this DNP Project.  Next, in all of the literature found, few 
studies directly studied the effects of ACP specific to those of the CKD population.  A 
majority of the data found was in the form of qualitative data and this was a slightly 
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different approach than was desired for this DNP Project.  While these results were still 
beneficial to this patient population, it was difficult to correlate an effect to a project that 
hoped to achieve both significant quantitative and qualitative results.  In addition, CKD 
patients are unique in regards to their end-of-life needs.  Treatment options for this 
chronic condition, such as dialysis or transplantation, are very limited and are often only 
approached with this group of patients when the disease progresses.  Withdrawal or 
continuation of this treatment can be the difference between life and death for these 
patients.  Patients without this chronic condition may never have to consider these 
options and these topics should be removed from their ACP process unless it is truly 
needed.  For this reason, it was important to implement an intervention specific to this 
group discussing dialysis and other forms of renal replacement therapy.  A lack of these 
interventions was found despite the great need that exists for this population.  A 
standardized process to better implement ACP was lacking in all groups and this was 
easily seen in the above literature review.     
Evidence-Based Practice Model 
The Iowa Model of Evidence-Based Practice to Promote Quality Care was the 
basis for this DNP Project.  This model has been revised a number of times with the most 
recent update in 2015 (see Figure 1).  The University of Iowa Hospital & Clinics model 
provides a guideline for implementing research into nursing practice.  Nurses and other 
health care staff can make meaningful decisions that result in improved patient outcomes.  
The model is not a one step process but instead consists of multiple phases with several 
feedback loops.  Today, current evidence helps to guide nursing actions.  The Iowa 
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Model stresses the use of the best evidence throughout its multi-step process (Titler et al., 
2001).   
The Iowa Model was the evidence-based practice change model used at the health 
care institution where this DNP Project was implemented.  This factor allowed the project 
to be more easily accepted and disseminated into practice.  This model was chosen for its 
ease of use, its practicality when addressing a clinical problem, and its effectiveness with 
problems of similar interest.  An identified need existed to routinely adopt the use of ACP 
in patients with CKD stages four and five.  The steps of the Iowa Model allowed this 
change to be addressed and implemented successfully in an effective problem-solving 
process.   
The steps of the Iowa Model are detailed below.  First, the practice question must 
be developed by identifying trigger issues and opportunities (Titler et al., 2001).  CKD is 
a highly prevalent condition yet few individuals had participated in the unique process of 
ACP or had formulated an AD document stating their preferred wishes for the end-of-life.  
Discussion with nephrology health care providers and personal experience of the DNP 
Project coordinator triggered the development of this project to enhance continuity and 
quality of care at the end-of-life and to decrease stress for both patients and family 
members.  A gap existed in the routine care of patients with chronic health conditions.  
ACP is a standard of care that all patients should undergo, especially those with CKD.   
Next, the question or purpose of the change must be developed to help guide the 
project towards its goal.  If the identified issue is a priority, the process can continue on.  
If not, other trigger issues must be considered (Titler et al., 2001).  The guiding PICOT 
question was developed at this point in the project.  This question served as the basis for 
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the remainder of the project, listed the detailed specifics of the project, and identified the 
over-arching goal of the project.  Then, a team was developed to help focus the clinical 
question, evaluate evidence, and design and evaluate the practice change (Titler et al., 
2001).  Stakeholders are necessary to help implement a successful change.  The key 
stakeholder in this DNP Project was a nephrology NP.  This individual agreed with the 
identified need to target patients with CKD stages four and five with an ACP discussion 
and agreed to help implement this project in the clinic setting.  The nephrology NP was 
not specifically trained in the process of ACP but she did have a long-standing history of 
working with the CKD population and was well-versed in motivational interviewing and 
conversation with patients of all ages.  As this project progressed, this person was able to 
help determine if and when changes needed to be made to the intervention and helped 
evaluate the effectiveness of the practice change.     
A literature review is the next step to undertake in the Iowa Model.  This is done 
to help assemble, appraise, and synthesize the body of evidence.  If there is sufficient 
evidence, the change can continue.  If not, feedback loops exist to redesign the change or 
formulate another, more important practice change (Titler et al., 2001).  A literature 
review was described in detail.  Using several databases, information was gathered to 
assess for the effectiveness of ACP in patients with CKD.  However, a gap was found in 
regards to available evidence in this category.  While this may represent a great barrier to 
implementing this change, it was identified that a large body of research exists in regards 
to ACP with other patient populations.  This sufficient evidence strengthened the need for 
this project and helped to provide a basis for this practice change.  The change continued 
and the intervention was implemented.         
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The change is designed and piloted after it has been evaluated.  Based on the data 
collected, a determination is made regarding the project.  A conclusion is reached 
whether the change is appropriate for adoption into clinical practice.  On-going 
evaluation and revisions take place as necessary throughout the process to help sustain 
the change and ensure effective results are achieved (Titler et al., 2001).  Chapter three 
lists the detailed methods, procedures, tools, and statistical approach that were used with 
this project.  Data was collected and assessed for statistical significance after the 
intervention had been implemented for a time period of three months.  Based on these 
results, conclusions were reached as to whether ACP was effective in patients with CKD.  
This DNP Project’s purpose was to achieve a clinically significant change in the 
knowledge of the ACP process, in the number of patients and/or family members 
participating in ACP discussions, and in the number of AD documents completed with 
the sample population.   
The last important step is dissemination into practice to share the findings and 
help others implement the same change, despite the results (Titler et al., 2001).  Chapter 
four of this project discusses the exact findings and chapter five forms conclusions for 
future practice.  It was the goal of this project to provide others with valid data and results 
that guided ACP as a standard of care in the management of patients with CKD.  Just as 
this project was guided by research and data not specific to those with this condition, this 
project also served as the basis for the care of all patients.       
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Figure 1. The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in 
Health Care.  Used/reprinted with permission from the University of Iowa Hospitals and 
Clinics.  Copyright 2015.   
 
Theoretical Approach 
 Viktor Frankl’s Theory of Meaning (1938) guided the theoretical approach to this 
DNP Project.  Essential to human nature is the question: Why am I here?  This question is 
necessary but should be answered by the individual alone.  Even in patients who have 
been diagnosed with a chronic disease, there remains a will to live in each and every 
individual.  The Theory of Meaning hopes to divulge this meaning and determine what 
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can be done to help the patient achieve meaning in life.  Internal conflict is a normal, 
natural process and is also part of this theory.  Four recommendations exist in this theory: 
a person’s search for meaning is the primary motivation of life; a person is responsible 
for the meaning of life; a person may find meaning in life even in the face of a hopeless 
circumstance; a life offers meaning in every moment (see Figure 2).  This theory has been 
used successfully in many other areas of health care and is often the basis for working 
with those with chronic illnesses (Frankl, 1984).   
 The most unique reason why this theory fits into this DNP Project is at any point 
in life, the individual’s meaning of life may change (Frankl, 1984).  Those with any 
chronic disease, but especially CKD, can benefit from discovering their true meaning in 
life.  Herein lies the necessity to partake in an ACP discussion and complete an AD.  
Starting this discussion and involving family members or close friends allows the patient 
to truly ponder what it is he or she wants for his or her life.  Long-term goals can be more 
realistically set without other unnecessary stressors, such as a major health crisis, 
influencing his or her decision.  The ultimate purpose of this DNP Project was to clarify 
the desires, wants, needs, and goals for patients with CKD and to avoid difficult decisions 
and a death incompatible with their wants and goals.  The patient’s true meaning of life 
was discovered and their individualized treatment plans were developed from this 
meaning through an ACP discussion.  As was discussed in the literature review, the ACP 
process needs to occur over the course of several office visits and should also be revisited 
on a regular basis.  Having an open and honest discussion with the patient was the first 
step and this was where ACP fell into place with these patients.   
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 Life purpose is the ultimate goal to be achieved with the Theory of Meaning 
(Frankl, 1984).  This allows a person to feel called and dedicated to what one does.  
Essentially, it is helping making the world a better place through actions.  An individual’s 
life purpose is unique and must be explored before any complicated and stressful 
decisions can be successfully made (Frankl, 1984).  When implementing an ACP 
discussion, a health care provider will need to help the individual determine what it is 
they want to live for and what it is they want to accomplish.  Patients with CKD are 
vulnerable due to the irreversible nature of the condition but it was still necessary to help 
them divulge the true meaning of their life.  A trusted health care professional remains 
the most competent individual to start this discussion.  This necessitated the need for this 
project to be undertaken in the outpatient setting.   
 Freedom to choose is the second main component of the Theory of Meaning 
(Frankl, 1984).  The freedom to choose exemplifies the process of choosing which 
options a person has control over.  It clearly explains when a person is presented with two 
options, why one person chooses a certain option (Frankl, 1984).  Again, this is a very 
individualized process and is based on one’s attitude.  An individual’s life purpose can be 
more easily met in an ACP discussion by helping the patient explore those attitudes and 
choose what he or she wants for his or her last few days of life.  A patient who feels in 
control of his or her actions is more likely to trust the health care provider who supports 
this practice and remain consistent with his or her goals and wishes at the end-of-life.   
 Human suffering is the final component of Frankl’s theory (Frankl, 1984).  In line 
with each of the other components of this theory, what causes suffering for one person is 
very different from another.  Suffering is an all-consuming experience, comprising an 
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array of emotions.  However, unique to suffering is not the exact meaning of the 
experience but how one responds to the situation that helps the individual progress 
through the Theory of Meaning (Frankl, 1984).  CKD is a diagnosis that triggers 
suffering in any individual.  In many cases, the suffering is prolonged and the patient is 
instead confronted with an array of issues when a health crisis occurs.  Discovering what 
causes suffering in a patient is essential and this is a key component of an ACP 
discussion.  The cause of suffering can be eliminated and the patient can be allowed to 
respond how he or she chooses.  Together with life purpose and a freedom to choose, an 
ACP discussion stimulated these concepts to be brought forth and the patient was allowed 
to experience a greater quality of life consistent with his or her goals and wishes.  The 
Theory of Meaning is an all-encompassing process that successfully brought forth the 
real need for ACP in patients with CKD.   
  
Figure 2. The Theory of Meaning. (Smith & Liehr, 2014, p. 97) 
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Change Theory 
 James Prochaska’s and Carlo Di Clemente’s Transtheoretical Model (TTM) 
served as the guiding change theory for this DNP Project.  The principle behind this 
model is an individual progresses through five specific stages when attempting to change 
a behavior, regardless of what the behavior is.  The five stages of changes are: 
precontemplation, contemplation, preparation, action, and maintenance.  Transitioning 
from one stage to another helps an individual achieve a successful behavior change but it 
is also common for a person to go back and forth between theses stages, such as is 
depicted in the spiral model in Figure 3 (Prochaska, DiClemente, & Norcross, 1992).  
Key concepts from psychotherapy and previous works in behavior change helped 
Procashka and Di Clemente to invent this theory in the early 1980s.  This theory was 
initially derived while helping individuals quit smoking.  Since that time, the TTM has 
been used successfully in helping others adopt change in many health related behaviors, 
such as alcohol use, anxiety and depression, eating disorders and obesity, and medication 
compliance (Prochaska, Redding, & Evers, 2008).   
 The TTM was utilized when attempting to elicit a behavior and knowledge 
change from patients with CKD in regards to ACP.  End-of-life decision making is a 
complex process and can involve a fluctuation between the individual stages included in 
the TTM.  As health care providers come to understand the process of behavior change 
and determine what stage each individual is in, specific strategies and interventions can 
be utilized to help the patients reach the latter phases of action and maintenance.  The use 
of the TTM in regards to the process of ACP is described below.     
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 The first stage of the TTM is precontemplation.  An individual in the 
precontemplation stage has no intention to change the behavior in the foreseeable future.  
Essentially, they are unaware that a problem exists (Prochaska et al., 1992).  Patients with 
CKD without an AD or those who have never participated in ACP before have no 
knowledge of the benefit this process could have on their end-of-life goals.  This could 
occur for many reasons, such as a lack of knowledge of the ACP process or a lack of 
knowledge of the correct use of ADs.  However, whatever the reason as to why the 
patient was in the precontemplation stage, it did need to be brought to the patient’s 
attention what the behavior to change was and why it was beneficial to change.  This 
stage of the TTM focused on education of the individual during the office visit with the 
nephrology NP and other support persons to enhance a patient’s overall knowledge.  This 
brought the idea of a behavior change to the forefront of the person’s mind. 
 The second stage of this model is the contemplation stage.  This stage involves an 
individual who is aware that a problem exists.  This person is seriously thinking about 
making the identified change but has yet to make a commitment to act.  The 
contemplation stage involves a person weighing the pros and cons of changing the 
identified behavior and the proposed solution (Prochaska et al., 1992).  Education of the 
process of ACP and the completion of ADs resulted in a person who was aware of the 
process and actively thinking about participating in this intervention.  Internally, the 
individual needed to think about what they wanted to experience at the end-of-life, who 
they wanted to have this discussion with, and if they were ready to partake.  A person can 
remain in this stage for any period of time, heavily weighing the pros and cons of the 
proposed behavior change.  Similar to the first phase of this model, this phase also 
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focused on individual education with the nephrology NP and allowed the individual 
adequate time to make the commitment to change.     
 The third stage of the TTM is preparation.  This stage combines components of 
intention and behavior.  Persons in this stage are intending to take action within the next 
month but have not previously made this same change within the past year (Prochaska et 
al., 1992).  An individual was made more aware and more knowledgeable of the process 
of ACP with the intervention tool, which helped the patients to progress to this stage.  
During successive office visits that involve ACP, the patient can continue to strive to 
reach this stage and be able to state exactly what his or her wants, needs, and desires for 
his or her end-of-life care are.  An individual in the preparation phase of ACP formulated 
their own AD document and discovered their true meaning in life, as is in line with 
Frankl’s Theory of Meaning.  Persons in this stage understood the importance of the 
behavior change and were willing to reach the next stage.   
 The next stage involves action.  Action is the stage that involves the actual 
behavior change.  Individuals here modify their behavior or environment in order to 
overcome their problems.  This stage is where visible actions occur but this is not reached 
without a great amount of time, dedication, and energy from the individual (Prochaska et 
al., 1992).  The action stage of this intervention involved completing the intervention tool 
and having a thorough discussion with one’s family members, close friends, or health 
care providers.  Action was acknowledging that a behavior change was needed and 
actually carrying out that change.  This stage was not easily reached but was one with the 
greatest reward for the patient as a person determined what it was he or she wanted for 
his or her end-of-life care.   
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 Finally, the maintenance stage is reached.  This stage involves a person working 
to prevent relapse.  Oftentimes, this stage is never ending and an individual must 
continually work to sustain the behavior change (Prochaska et al., 1992).  The individual 
completed the intervention tool, had a discussion with the nephrology NP and/or his or 
her family members, and upheld his or her decisions in his or her daily life.  The static 
process of ACP allowed for an individual to go back and forth between the various 
phases, as is an important component of the TTM.  If, throughout future office visits or if 
a major change in life occurs, a person can go back to the preparation phase, determine 
what he or she wants to change, and then successfully move through the action and 
maintenance phases as necessary.  It is important to understand that this model relies 
heavily on education in order to help a person adopt a successful and long lasting 
behavior change.                 
 
Figure 3. Transtheoretical Model. (Prochaska et al., 1992, p. 1104) 
   
 
 
ADVANCE CARE PLANNING                                                                                      38 
  
Chapter 3 
Method and Procedures 
Introduction 
 This DNP Project was developed to address the aforementioned proposed PICOT 
question utilizing a quality improvement approach in the design phase of the Iowa Model.  
Based on the needs of the health care institution and the DNP Project coordinator 
experience, the setting and sample were chosen.  A five question validated and appraised 
CPG was utilized as the main intervention and served as the ACP discussion guide 
throughout this project.  Changes in patient knowledge of the ACP process were also 
assessed utilizing a six question pre-test and post-test document.  Below is a detailed 
structure of the procedure and analysis, based on various potential impacts, 
considerations, barriers, and stakeholders.   
Design/Approach  
 This project was focused as a quality improvement project.  Quality improvement 
projects are based on an organized, evidence-based, systematic process designed to 
ensure patients are provided care that is addressed in a reliable manner.  Quality of care 
provided to patients is enhanced due to current evidence that has been implemented into 
practice throughout other projects such as this.  A working hypothesis is necessary in a 
quality improvement project.  Projects of this type are usually low risk to a patient and 
are becoming more routine in today’s clinical practice (Melynk & Fineout-Overholt, 
2011).   
 The literature review completed showed the necessity of integrating ACP into 
routine health care practices.  Several studies have shown the effectiveness this process 
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has had on patients with other chronic conditions but data was lacking in regards to those 
with CKD.  Using successful interventions and validated CPGs, ACP was used to 
improve the care of patients with CKD.  A clinical hypothesis or PICOT question guided 
this quality improvement project.  This process has the potential to translate to other areas 
of health care as a more routine and effective process.   
 This quality improvement project involved a retrospective chart review.  The 
retrospective chart review served as the comparison group for this DNP Project.  The 
population who received the intervention was a non-randomized convenience sample of 
patients with CKD stages four and five who were seen in the clinic setting by a 
nephrology NP.  Both samples were similar in characteristics yet were a different group 
of individuals.  A detailed discussion of the tools and procedures this project involved is 
described below.     
Setting 
The project setting was an urban Midwestern nephrology clinic located in a town 
of approximately 180,000 people (U.S. Department of Commerce, 2015).  The clinic was 
attached to a main hospital campus.  Specialized nephrology care was provided to adult 
patients 18 years of age and older who came from both rural and urban backgrounds.  
Many patients traveled over 100 miles to be seen in this clinic.  Time of travel for 
patients averaged between two and four hours; however, some patients drove up to six 
hours to be seen in this clinic.  Patients also traveled from various surrounding states, 
including Iowa, Minnesota, and Nebraska, to utilize the services provided in this setting.  
Telemedicine services were provided to remotely access patients in rural settings in both 
South Dakota and Minnesota.  Most patients were middle class but income levels varied 
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from the very poor to the very wealthy.  Those with both acute and chronic renal issues 
were seen in this clinic (A. Saeger, personal communication, June 21, 2016).   
This clinic was staffed by four physicians (including three Medical Doctors and 
one Doctor of Osteopathy), two NPs, four registered nurses, one licensed practical nurse, 
and two schedulers/receptionists.  No interdisciplinary team members were employed in 
this clinic.  A social worker and dietician were available by telephone but they did not 
routinely see patients in the clinic setting unless a specific need was identified by a 
provider.  A clinic manager was available to provide notary services at the time of AD 
completion. 
Combined, the six health care providers had more than 40 years of experience in 
the nephrology setting, including patients on both hemodialysis and peritoneal dialysis.  
A specialized area of interest of all providers was hypertension management.  Most 
providers were educated in urban areas with a focus on nephrology management.  Nine 
exam rooms were utilized between the six providers.  Approximately 60-80 patients were 
seen each week by all of the providers.  The key stakeholder, one nephrology NP, in this 
project saw approximately 10-20 patients in the clinic setting each week.  Appointment 
times varied based on patient diagnosis.  New patient appointments averaged 40 minutes 
in length while follow-up visits were routinely 20 minutes.  Laboratory and x-ray services 
were not provided in this clinic.  However, a laboratory facility was located in the 
basement of the same building and x-ray services were provided at the main hospital 
campus (A. Saeger, personal communication, June 21, 2016; K. Jerke, personal 
communication, July 5, 2016).   
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Sample 
The sample for this project was a non-randomized convenience sample of patients 
with CKD stages four and five without an existing AD document who were seen in the 
clinic by one nephrology NP.  Inclusion criteria for the intervention sample included 
adult patients over 18 years of age.  Patients of all ethnicities and races were included in 
the project sample, as well as those of all genders.  While English was the major language 
spoken among the patients in this clinic, those who were non-English speaking were also 
included in the sample.  Translator services by the use of phone, iPad, or live interpreter 
were available and provided to these patients.  One iPad used for translator services only 
was available from the clinic receptionist staff.  If a trained medical interpreter was 
needed, the nursing staff arranged for this service prior to the patient’s scheduled 
appointment.  The informal letter of invitation, informed consent form, knowledge 
assessment, and intervention tool were not translated into individual languages.  It was 
necessary to go through each document with the interpreter service, patient, and family 
members to ensure they were knowledgeable of the process, willing to participate, and 
were able to actively engage in the ACP discussion.  A large majority of the population 
seen in this clinic was Caucasian, followed by persons of Native American and African 
American descent (A. Saeger, personal communication, June 21, 2016).  Cultural 
differences were addressed on an individual level.  It was the aim of this project to help 
an individual incorporate ACP into his or her medical care while also respecting the 
cultural beliefs and values one may have.  It was hoped that all genders were equally 
represented in this DNP Project.   
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Due to the many coexisting conditions that occur with CKD, those who received 
the intervention had an array of comorbid conditions.  Hypertension, diabetes, and 
peripheral vascular disease were a few of the most common comorbid health conditions 
this sample had.  Those with conditions that impair brain functioning and/or limit 
decision making capacity (such as dementia and Alzheimer’s disease), however, were 
excluded from this sample due to the nature of the intervention and the great need for 
adequate decision making capacity to state one’s goals and desires for their end-of-life 
care.  This was determined based on past medical history or discussion with family 
members or caregivers.  In addition, patients who already had an AD document were 
excluded from the project sample per the health care institution’s request.  These factors 
were the only exclusion criteria utilized in the intervention.        
 The comparison sample was patients from one year ago at the time of project 
implementation with CKD stages four and five who were seen in the clinic setting by the 
same nephrology NP.  Patients who were part of the comparison sample were not 
included in the project sample.  A thorough chart review ensured the comparison sample 
and intervention sample did not overlap.  Comparison sample data was gathered and 
reviewed from January 1, 2016 to March 31, 2016.  All patients reviewed were similar in 
characteristics to the intervention sample.  The inclusion criteria for the comparison 
sample was the same as that listed for the intervention group.  Comparing these two 
groups at the time frame of one year ago limited the influence of extraneous variables and 
other biases that may have occurred with one sample and not another, thereby providing 
the most accurate results for this DNP Project.  The estimated sample size of this project 
was n = 20-30.         
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Development of Intervention/Tools 
 The intervention for this DNP Project was the implementation of a standardized 
ACP discussion tool.  This intervention replaced the usual care currently received and 
allowed patients with CKD to focus on goals of care specific to this patient population.  
Five specific questions were recommended by the Renal Physicians Association and the 
American Society of Nephrology as being critical to implement in ACP in patients with 
CKD (Renal Physicians Association & American Society of Nephrology, 1999; AHRQ, 
2015).  The five questions were:   
1.  If you become unable to make decisions for yourself, whom do you want to 
make decisions for you? 
2.  If you had to choose between being kept alive as long as possible regardless of 
personal suffering or living a shorter time to avoid suffering and medical 
procedures such as breathing machines and feeding tubes, which would you pick? 
 3.  Under what circumstances, if any, would you want to stop dialysis? 
4.  Under what circumstances, if any, would you not want to be kept alive with 
medical means such as cardiopulmonary resuscitation, a feeding tube, or 
mechanical ventilation? 
5.  Where do you prefer to die and whom do you wish to be with when you die? 
(Renal Physicians Association & American Society of Nephrology, 1999; AHRQ, 
2015, pp. 47) 
From these questions, a one-page document was developed to use as the intervention and 
primary tool for this project.  The Renal Physicians Association granted permission to use 
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this document as part of this DNP Project (see Appendix I).  Appendix L shows the 
specific document used. 
 The Agree II tool was used by the project coordinator and three other DNP 
students to appraise the CPG (Agree Enterprise, n.d.).  All persons were familiar with and 
had experience using this tool.  The CPG was recommended for use by all four 
individuals and was rated, on average, a 5.75/7.  This demonstrated the high quality of 
the CPG and showed how necessary it was to implement into current practice.  In 
addition to the overall high average rating received, the overall objectives of the guideline 
were clearly stated, systematic methods were used to search for available evidence, key 
recommendations were easily identifiable, and the recommendations were specific and 
unambiguous (Agree Enterprise, n.d.).  The CPG discussed methods used for data 
extraction that greatly strengthened the validity of the project and discussed congruence 
of the CPG with several nephrology physicians, which also increased the reliability of the 
document (Renal Physicians Association & American Society of Nephrology, 1999; 
AHRQ, 2015).   
 A six question pre- and post-intervention knowledge assessment was given to 
patients to determine their increase in knowledge about ACP and ADs after the 
implementation of the intervention.  These questions were adapted from a RCT that 
assessed change in knowledge of medical students of the ACP process after a 
computerized intervention.  These questions were developed through a thorough 
literature review and both face and content validity were verified prior to their 
implementation (Green & Levi, 2011).  Both multiple choice and true/false questions 
were included.  The six questions were: 
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1.  An advance directive is a document that: 
o Expresses an individual’s medical wishes when that person is unable to 
speak for him- or herself 
o Determines who will handle one’s financial affairs after death  
o Explains one’s rights as a patient  
o I don’t know 
 
2.  Advance directives go into effect if an individual: 
o Gets admitted to the hospital 
o Has a terminal medical condition 
o Can no longer communicate his or her health care decisions 
o I don’t know 
 
3.  In general, the best person to serve as an individual’s health care surrogate is 
the person who: 
o Has the most knowledge 
o Is best able to represent the individual’s views 
o Has known the individual the longest 
o I don’t know 
 
4.  Of the following, which is least important for a patient to do regarding advance 
care planning? 
o Discuss their values and wishes regarding end-of-life care with trusted 
family members and friends 
o Create an advance directive that explains their goals of care 
o Provide their physician(s) with the advance directive 
o Use a state-specific living will form 
 
5.  Advance care planning is a one-time process and does not need to be revisited 
during the course of a patient’s life.   
o True 
o False 
 
6.  If an individual has decision-making capacity and can still speak for him- or 
herself, an advance directive does NOT determine which medical treatments they 
will receive.  
o True 
o False (Adapted from Green & Levi, 2011, pp. 88-90) 
 
From these questions, a one-page document was used to assess a patient’s baseline 
knowledge prior to the intervention.  The same questions were used to assess a patient’s 
change in knowledge following the completion of the intervention.  Appendices J and K 
show the specific documents used.    
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Project Procedure 
 This project transitioned into the implementation phase after obtaining both the 
health care organization and university’s Institutional Review Board approval.  A 
retrospective chart review was completed from one year ago at the time of 
implementation to gather information on the comparison sample.  The actual chart review 
process was conducted during the first week of this DNP Project implementation period.  
A chart review was done to determine the number of patients with CKD stages four and 
five who were seen by the same nephrology NP who had a documented ACP discussion 
and the number of patients who had a completed AD document in their electronic 
medical record.  These baseline numbers helped to determine the amount of change that 
occurred with this project in a similar patient sample seen at the same time of the year 
and who were seen by the same provider in the same clinic setting.    
 One to two weeks prior to project implementation, a meeting was held with the 
nephrology NP, clinic manager, members of the nursing staff, and the clinic receptionists 
to review the informal letter of invitation, informed consent form, intervention tool, and 
pre- and post-intervention knowledge assessment document.  A routine process of 
implementing all parts of the intervention were discussed.  These staff members were 
provided with an algorithm document to assist in the process of completing all of the 
steps of the intervention (see Appendix O).       
Each working day during the three month intervention period, the nephrology NP, 
clinic nurses, and receptionists determined from the scheduled patients those who were 
eligible to receive the intervention.  An asterisk was made next to each eligible patient on 
a printed clinic schedule that was placed at the front desk.  The nephrology NP and the 
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other involved stakeholders were knowledgeable of who was to receive the informal 
letter of invitation, informed consent form, pre- and post-intervention knowledge 
assessment document, and intervention tool for that day and fulfilled their role in the 
intervention as detailed below.  The DNP Project coordinator was not readily available in 
the clinic setting during the implementation period but checked-in with the nephrology 
NP on a weekly basis and was available by telephone if questions or concerns arose.     
The clinic receptionists gave each eligible patient an informal letter of invitation 
from the DNP Project coordinator (see Appendix M).  While waiting to see the 
nephrology NP, the patient had time to formulate any questions in regards to the details 
of the project.  The nursing staff answered these questions while rooming the patient.  
The patient then selected one option on the bottom of the informal letter of invitation, 
either I agree to participate or I decline to participate.  The completed informal letter of 
invitation was given to the nurse.  All forms, even if the patient declined, were kept in a 
locked filing cabinet, only accessible by nursing staff, the key stakeholder, and the 
project coordinator.  After this step, the nurse then asked the patient if he or she had an 
AD document.  If the patient did, usual care ensued and the patient was not eligible for 
the intervention.  The office visit went on as originally scheduled.  If the patient did not 
and agreed to participate, the intervention would have continued, in addition to the 
scheduled office visit for that day.     
If the patient did not have an AD document and would have agreed to participate, 
the nurse would have provided the patient with the informed consent form (see Appendix 
N).  The nursing staff would have collected the completed informed consent form from 
the patient during the rooming process.  These forms would have been stored in a locked 
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filing cabinet only accessible by nursing staff, the key stakeholder, and the project 
coordinator.  After the nurse completed her rooming procedure, the patients who 
consented to the intervention would have been given the pre-intervention knowledge 
assessment document to gather baseline data of patient knowledge in regards to ACP and 
ADs.  The assessment tool would have been returned to the nursing staff or nephrology 
NP.  These assessments would have been stored in the locked filing cabinet only 
accessible by the nursing staff, the key stakeholder, and the project coordinator.  The 
nephrology NP would have then provided the intervention to the eligible and consenting 
patients using the developed intervention tool.   
The nephrology NP would have had a discussion with the patient and/or 
individual(s) who were present at the time of the appointment using the developed 
intervention tool.  This intervention would have replaced usual care.  The patient would 
have been encouraged to complete the form at the time of the visit, discuss his or her 
wishes with the nephrology NP, or take the form home to discuss with family members 
and fill out at a later date.  If the intervention tool would have been completed at the time 
of the office visit, the clinic manager would have served as the notary to witness the 
signing of the AD document.  The nephrology NP would have then given the document 
to a member of the nursing staff who would have ensured the document was scanned into 
the patient’s electronic medical record.  A copy would have been sent to the medical 
records department and the original document would have been kept in the locked filing 
cabinet in the clinic.  These forms would have been only accessible by the nursing staff, 
the key stakeholder, and the project coordinator. 
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Finally, the same knowledge assessment tool would have been given to the patient 
in the form of a post-intervention knowledge assessment document.  This would have 
been given to the patient by either the nephrology NP or any member of the nursing staff.  
The patient would have given the completed assessment to either the nephrology NP or 
any member of the nursing staff.  As similar to the pre-assessment, the post-intervention 
knowledge assessment documents would have been kept in the same locked filing cabinet 
only accessible by the nursing staff, the key stakeholder, and the project coordinator.    
 The nephrology NP would have given each eligible and consenting patient an 
identifying patient number.  This number would have been placed onto the patient’s 
informal letter of invitation, informed consent form, intervention tool, and pre- and post-
intervention knowledge assessment documents.  This would have allowed all completed 
forms for each patient to be grouped together for a more streamlined approach to data 
collection after the completion of the intervention.    
The nephrology NP would have been encouraged to document the ACP 
discussion in the patient’s progress note in the electronic medical record.  If the patient 
did not complete the intervention tool at the time of the clinic visit, he or she would have 
been encouraged to return the form to a clinic staff member as soon as he or she felt 
ready.  The same procedure for medical record documentation would have occurred any 
time during the implementation period when a patient returned the intervention tool to the 
clinic staff members, including scanning the form into the electronic medical record, 
sending a copy to the medical records department, and keeping the original form in the 
locked filing cabinet only accessible by the nursing staff, the key stakeholder, and the 
project coordinator.   
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At the end of the three month time period, the patient sample was reviewed to 
determine the number of ACP discussions completed and the number of intervention 
tools received to help determine the change this intervention had on the sample.  In 
addition, the change in knowledge from the pre-intervention knowledge assessment 
would have been measured against the post-intervention knowledge assessment to 
determine the amount of knowledge the patients obtained from participating in this 
intervention.  As similar to the comparison sample, the same demographic data (age 
range of the patient, gender of the patient, race of the patient, and stage of CKD) were 
collected with the intervention sample to aid in determining factors which promoted or 
hindered this change.  Weekly check-ins and discussions with the stakeholders by the 
DNP Project coordinator were a necessary process to help identify any changes that 
needed to occur, discuss any barriers the nephrology NP or other staff members were 
encountering, and review any successes or set-backs the project was experiencing.   
Ethical Considerations 
 This DNP Project was proposed to the health care institution’s Institutional 
Review Board and Nursing Research Council for approval (see Appendices B and C).  
Once approval was obtained, the project was submitted for approval to the DNP Project 
coordinator’s university Institutional Review Board (see Appendix A).   
 The retrospective chart review data included demographic data as well as the 
number of patients who had completed an ACP discussion and the number of 
documented ADs.  This information was stored in the same locked filing cabinet only 
accessible by the nursing staff, the key stakeholder, and the project coordinator.  The 
intervention tools, pre-intervention knowledge assessments, and post-intervention 
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knowledge assessments would have been collected and stored in the same manner 
following informed consent.  All data was collected electronically and was de-identified. 
This project placed a patient at a low risk from an ethical standpoint.  An ACP 
discussion collects information about sensitive end-of-life issues and asks questions that 
could possibly cause psychological distress, discomfort, and anxiety beyond what is 
experienced in daily conversation.  This project was a necessary component of the care of 
patients with a chronic condition, such as CKD, despite the known risk.  A patient was 
able to withdraw from the project at any time.  If this did occur, usual care ensued from 
the nursing staff and nephrology NP and the appointment went on as previously 
scheduled.  There were no repercussions to the patient for withdrawing from the project.     
If information needed to be stored for the DNP Project coordinator, it was kept in 
the locked filing cabinet in the clinic.  This information will be kept for a total of six 
years in order to comply with university Institutional Review Board requirements.  
Electronic ACP and AD documentation will be accessible by anyone directly caring for 
the patient, including nursing staff, health care providers, and the project coordinator.  
Health Insurance Portability and Accountability Act (HIPAA) and electronic medical 
record accessibility was maintained for this reason.   
Projected Analysis 
 Demographic data collected included the age range of the patient, gender of the 
patient, race of the patient, and stage of CKD.  This data was analyzed using frequencies 
and percentages and aggregate demographic data was displayed.  Data was gathered to 
assess for the change in the number of patients who participated in an ACP discussion 
and/or who had an AD document completed after the intervention.  Due to the nature of 
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this part of the project and the different comparison group used for analysis, an 
independent, or unpaired, t-test would have been used to assess for a statistically 
significant change after the completion of the intervention.  The two groups were 
independent of one another and were different in regards to sample size; hence the use of 
the independent t-test.  An independent t-test compares the means of two groups of data, 
which was the overall objective of this DNP Project.  The level of significance, or p-
value, was set at p < 0.05.  This specific p-value was chosen over a p-value of 0.1 to 
provide more significant data that a true difference was detected in the actual data 
gathered.     
 Data was also analyzed to assess for a change in the level of knowledge patients 
have of the ACP process and the use of ADs after the intervention.  Due to nature of this 
part of the project and the same comparison group used for analysis, a dependent, or 
paired, t-test would have been used to assess for a statistically significant change in 
knowledge after the completion of the intervention.  The two groups were dependent of 
each other; hence the use of the dependent t-test.  A dependent t-test compares the means 
of the same two groups of data, which was also another overall goal of this DNP Project.  
The level of significance, or p-value, was set at p < 0.05.  This specific p-value was 
chosen over a p-value of 0.1 to provide more significant data that a true difference was 
detected in the actual data gathered.       
Environmental and Organizational Context  
 The vision of this health care institution is dedicated to improving the human 
condition.  ACP is a process that can easily help improve the human condition.  Helping 
patients identify what their goals and wishes are for end-of-life care before a change in 
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health occurs, before the patient is unable to make his or her own decisions, or before the 
thought even crosses the patient’s mind is necessary to improve and promote a higher 
quality of life near the end-of-life.  Making patients aware of and presenting them with 
their treatment options gives them the necessary tools to consider their wants, needs, and 
desires for their last few months.  In the end, quality of life is greatly enhanced, all in line 
with the goal of improving the human condition.      
Courage, passion, and family are three core values of this organization and are 
also necessary to consider when implementing this DNP Project.  An ACP discussion is 
one that few providers undertake today.  This conversation involves feelings and 
emotions and is oftentimes not what the patient or family members want to hear.  It is a 
challenging topic to address with patients and often leaves patients, families, and 
providers feeling unsettled.  Many providers may be unsure of how to bring about this 
discussion and instead leave it unaddressed with their patients.  Courage is necessary to 
present the truth in a caring and compassionate manner.  Passion about the topic of early 
ACP and the use of ADs is also necessary to implement this project successfully.  Passion 
is shown by focusing on the patient and/or family during an ACP discussion and helping 
the patient identify his or her wants, needs, and desires for end-of-life care.  An open, 
honest, and trusting relationship between the involved parties is also essential and 
embodies passion from all of those involved.  Finally, family is another key value to 
consider when implementing ACP.  Many patients are close to their family members and 
are concerned about leaving them with difficult decisions to make.  This process helps 
eliminate stress and anxiety of those other individuals and also promotes a greater view 
of the dying process in light of ACP.     
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 Discussions with the nephrology NP and the clinic manager provided this DNP 
Project coordinator with overwhelming support (K. Jerke, personal communication, May 
19, 2016; A. Saeger, personal communication, June 4, 2016).  This organization’s 
Nursing Research Council also supported this project.  The Council identified a lack of a 
current work flow, a lack of AD documentation in the outpatient setting, and a lack of a 
standardized process of ACP specific to this patient population.  This DNP Project’s 
purpose was to address and improve all of these concerns, in addition to enhancing 
overall patient knowledge of the process of ACP.  As this project was implemented, 
support from the first two individuals was necessary and also helped to overcome any 
barriers that were experienced.  This project could not have been implemented alone, and 
as a team, successful changes were reached that could then be implemented as a routine 
practice throughout the entire clinic and health care organization.     
Stakeholders/Facilitators 
 The key stakeholder for this project was one nephrology NP.  She served as the 
primary implementer of the intervention tool and helped complete the chart review to 
determine changes in ACP discussion rates and AD completion rates.  This individual 
had a well-rounded experience working with patients with CKD and comprehended the 
necessity of this intervention and project.  Another stakeholder in this project was the 
clinic manager.  This individual, again, realized the necessity of this intervention and was 
willing to help pilot this project in the clinic setting.  This person also served as the 
notary to witness the signing of the AD documents if completed in the clinic setting.  The 
help of these two individuals allowed patients with CKD to achieve improved and more 
consistent outcomes with the implementation of ACP.   
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 The members of the nursing staff and the clinic receptionists were also 
stakeholders to this DNP Project.  Together, these individuals helped identify patients 
who were eligible for the intervention each day.  The clinic receptionists gave each 
eligible patient an informal letter of invitation at the time of appointment registration.  
Then, while rooming the patient, the nursing staff answered any questions the eligible 
patients had and collected the informal letter of invitation.  These individuals would have 
given the informed consent form to the consenting patients, would have gathered the 
signed informed consent form, would have completed the steps of usual care, would have 
administered the pre- and post-intervention knowledge assessment tool to the appropriate 
patients, and then communicated with the nephrology NP whether or not the patient 
consented and if he or she had an existing AD document.  The nursing staff would have 
helped gather the completed intervention and assessment tools.  They also would have 
ensured the completed intervention documents were placed into the patient’s electronic 
medical record.  The DNP Project coordinator worked closely with these individuals to 
ensure they understood their scope of the project and answered any questions as they 
arose.   
 As this project continued to move forward, the other providers in the clinic helped 
to serve as stakeholders of this project.  As the nephrology NP began to have these 
conversations with the patients she was seeing, the patients of other providers began to 
ask about these critical conversations.  Through word of mouth and realizing what a 
difference this intervention could have on their patients, the interest of the other providers 
increased and it is hoped that they will begin to adopt this into their own practice.  In 
addition, these individuals had personal experiences and ideas or suggestions to improve 
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this project.  The vast array of knowledge and personal experience of these providers 
served to help this DNP Project move forward and achieve successful results.     
 Finally, the health care institution at which this project was implemented was a 
stakeholder to the success of this intervention.  The Nursing Research Council of this 
organization allowed this project to move forward.  The Council hoped for great results 
to be achieved that can then be translated to other areas of this organization.  A clinical 
nurse leader stressed the necessity of the project to the DNP Project coordinator and was 
instrumental in launching the idea of this project.  The vision of this institution and three 
key values, courage, passion, and family, were achieved with this project.   
Potential Barriers  
 Barriers have a potential to occur with any project.  Time was a great barrier with 
this specific DNP Project.  This intervention was implemented for the time frame of three 
months, which may not have provided some patients with enough time to make these 
sensitive decisions or to identify all of their wants, needs, and desires.  As was discussed 
in chapter two, ACP is not a one-step process but instead needs to be revisited with each 
patient over several office visits.  The topics discussed with the five question intervention 
tool were a lot for a patient to process in one short office visit.  This was another valid 
reason why a greater period of time may have been more beneficial to the ACP process.  
A longer time period, such as one year, may result in more patients completing the 
intervention tools.  This may also result in more significant results and as such, would 
have a larger impact on this patient population.  Due to the time constraints of this 
project, that was not feasible.  The time frame chosen still allowed for successful results 
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to be achieved.  Based on these results, it would then be implemented for a longer time 
frame and with a larger sample of patients.   
The informal letter of invitation, informed consent form, pre- and post-
intervention knowledge assessment document, and discussion tool all had a very high 
readability level, around the 12th grade for all documents.  ACP and ADs bring about 
very challenging issues, and as such, do require a somewhat higher level of thinking in 
order to complete them successfully.  For some persons, it may be quite difficult to read 
and complete the tools and actively participate in the intervention for this reason.  The 
nephrology NP completing the intervention needed to consider this aspect during the 
implementation.  In addition, it was important to also understand that patients may need 
some extra time to read and comprehend all parts of the intervention.      
 This project had multiple steps and processes that required time and attention 
from nursing staff.  There was a great possibility that steps were missed in the process.  
Establishing a buy-in and providing an algorithm of the processes this project entailed 
helped prevent any aspects of the project from being missed.  Detailed meetings and 
discussions both before the start of the implementation period and also during the three 
month time frame helped to ensure all steps were being followed and all staff members 
were aware of what the expectations were.        
 The nephrology NP, chosen as the key stakeholder for this project, routinely 
rounds on patients in the hospital setting while also seeing patients in the clinic.  This fact 
served as a barrier as the sample of patients may be somewhat smaller as opposed to a 
provider that only sees patients in the clinic setting.  In addition, this nephrology NP may 
have needed to spend more time with patients implementing the ACP discussion and this 
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may have decreased the total number of patients she was able to spend time with in the 
clinic setting.  Overall, the productivity of the clinic could decline slightly, but the 
increase in long-term patient outcomes will override these productivity losses.  The clinic 
manager was aware of this barrier prior to the implementation of the intervention but was 
still willing to help the patients reach better and more consistent outcomes with ACP.     
Turnover in the clinic with both nursing and various support staff could also serve 
as a barrier to this project.  Changes in nursing staff and clinic receptionists during the 
course of the project may result in fewer patients being enrolled in the project and less 
significant results achieved.  In addition, more time may be required to train new staff in 
the process of this project and this may also result in fewer patients who are targeted with 
the ACP intervention.  Again, it was hoped that if this DNP Project was successful in the 
outpatient setting, this process could then be implemented in the inpatient setting.  
Having a provider who provided care in both settings helped to round out this project and 
will allow for easier translation in other settings and with other patient populations.     
 Finally, as with any project, a lack of patient participation and a lack of patient 
buy-in to the necessity of the project was a major barrier that could be encountered.  As 
was shown in the literature review, many patients lacked knowledge of ACP and did not 
see the necessity of completing an AD document.  Education is an essential component of 
this intervention in order to engage patients to participate and to help them see the 
necessity of this project.  As the nephrology NP implemented the project with each 
patient, questions were answered and the use of ACP and AD documents was addressed.  
Fully informed patients are more likely to participate with a trusting health care provider.  
However, if a trusting relationship is not first established between these two individuals, 
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the project will not be successful.  New patients to the clinic undoubtedly require more 
time to establish this relationship with the nephrology NP.  Nevertheless, these 
individuals were not excluded from the sample.  The nephrology NP used motivational 
interviewing and effective communication skills to establish a rapport with the patients.  
The ACP discussion could be undertaken and success could be achieved after this had 
been established.  These barriers provided potential set-backs to this DNP Project.  
However, once they were overcome, significant results could be achieved.     
Impact on: 
Organization.  This DNP Project was directly in line with the vision of the health 
care institution at which it was implemented, as was discussed above.  ACP helps to 
promote the human condition and directly achieves the three values of courage, passion, 
and family.  Two stakeholders at the participating organization saw the necessity of this 
project and were willing to pilot it in one outpatient clinic.  As this project progressed, it 
was important to involve several key organizational members to engage in and enable 
project dissemination.  It was hoped that significant results will be achieved to more 
easily allow this topic to be translated to other areas of health care.  Stressing the 
necessity of this project with all involved, educating patients, and involving health care 
staff may allow ACP to become a routine process in the care of all patients throughout 
this health care organization.    
Finances.  Costs were incurred to print the informal letter of invitation, informed 
consent form, intervention tool, and knowledge assessments but were minimal when 
completed in large quantities.  A major cost that could occur with this DNP Project was 
the increased time the health care provider spent with the patients having the ACP 
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discussion.  This may have resulted in less reimbursement received from insurance 
companies and federal organizations in addition to less time available to see other 
patients.  However, the cost savings of an ACP intervention greatly outweighs the costs 
incurred.  Individuals who participated in ACP and those who developed ADs more often 
choose treatment-limiting options.  Essentially, a higher quality of life may be 
experienced at the end-of-life with fewer invasive treatments, hospitalizations, intensive 
care unit (ICU) stays, emergency room visits, and medications needed to promote a 
sustainable life.  
Diagnosis codes used for Medicare patients are available for initial ACP 
discussions as well as each additional 30 minutes spent with a patient in this type of 
intervention (Centers for Medicare and Medicaid Services, 2016).  ACP is a reimbursable 
service for providers yet it was not a routine process in this outpatient clinic.  This fact 
stressed the need to make ACP a more consistent practice.  Providers do understand more 
time is necessary to participate in ACP.  However, if it is a billable service and they are 
reimbursed for their time spent with patients, providers should be more willing to 
participate and integrate this practice into the routine care of their patients, especially in 
those with CKD.   
Policy decisions.  If this project is successful at showing the impact ACP can 
have on a small sample of patients with CKD, ACP will need to become a routine 
practice in the care of all patients with a chronic health condition.  For that reason, strict 
policies and procedures will need to be developed to guide an ACP discussion if it is 
shown to be successful.  Key organizational leaders will need to be involved in this 
process in order to engage and promote dissemination into health care practices.   
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Quality of health care.  The greatest impact of this DNP Project rests on the 
improved quality of care that can be experienced with ACP.  Patients will benefit the 
most from an intervention of this type.  Their benefits include a higher quality of care 
experienced at the end-of-life, a care that is congruent with their wishes at the end-of-life, 
lower cost of care at the end-of-life, fewer hospitalizations and emergency department 
visits, and an enhanced relationship with their health care provider.  However, family 
members can experience a wide array of benefits from the use of ACP.  Family members 
can have less stress and anxiety about end-of-life decision making and feel more 
confident caring for their family member who has developed an AD or participated in 
ACP.   
Health care providers implementing the practice also benefit from choosing to use 
ACP with their patients.  They will have a greater connection with their individual 
patients and increased satisfaction in taking care of patients who are fully informed, 
satisfied, and aware of their diagnosis, prognosis, and treatment options.  Finally, as was 
discussed in the cost section, a cost savings and a smaller use of resources will result for 
the health care institution.  In the end, ACP is envisioned to be a routine process for the 
health care institution at large.  Policy making and changes after this project will ensure 
ACP is an expectation for both providers and patients at this organization.  Patients will 
expect to be asked these questions, to engage themselves in end-of-life decision making, 
and to develop goals and desires for their disease process.     
Rural or underserved populations.  This outpatient clinic served a wide-range 
of patients, including those who came from many small rural communities.  Those who 
live in a rural environment have less access to health care and less health care resources 
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to utilize.  Individualized patient goals can be tailored based on what treatments are 
available in the community or what would be most accessible to the patient.  Rural 
patients would benefit by having an increased awareness of services and options, which 
makes their end-of-life care more congruent with their goals and wants on an individual 
basis.  The educational component of ACP is essential with all patients, but especially 
those coming from a rural setting.  A higher quality of life is experienced for these 
patients with the help of ACP, even if access to health care and resources is less.       
Those with CKD are medically underserved for many reasons, such as a lack of 
available dialysis facilities, a lack of successful long-term treatment options, and a high 
cost of procedures and medications that only prolong their life for a short period of time.  
The use of ACP and the completion of ADs served to help limit these factors.  Patients 
increased their awareness of all of their treatment options but also chose to forgo such 
expensive, extensive, or invasive procedures having the full knowledge of what it all 
entails.  Again, the educational component of an ACP intervention was necessary to 
ensure this process was successful.  Patients with CKD who are more informed, educated, 
and satisfied experience a quality of life congruent with their wants, needs, desires, and 
treatment prognosis.  ACP helps to even the playing field for this underserved population 
and enhances quality of life without going through any unnecessary procedures, should 
the patient desire.   
Non-English speaking patients are also an underserved population.  These persons 
lack knowledge and literacy of health and health care and often do not seek health care 
due to the language barrier that exists.  Often times, when health care is sought, it is in 
emergency situations.  Health care providers do not have the knowledge of what a patient 
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would want at the end-of-life if he or she has not sought health care before.  Language 
barriers should not be a reason to not implement ACP in this patient population.  These 
patients need more time to understand the components of end-of-life care but it is 
essential to provide them with this service.  ACP with this patient population may result 
in more informed and educated patients who are able to access the health care system at 
all stages of life, even during the end-of-life.       
Summary 
 This DNP Project had the ability to reap great rewards for all of those involved.  
Utilizing a quality improvement approach with a retrospective chart review and the 
experience of a nephrology NP, patients with CKD stages four and five were given a 
valid and reliable ACP tool based on recommendations from a CPG.  It was the goal that 
the number of patients participating in an active ACP discussion and those completing an 
AD document would increase with this one-on-one individualized intervention.  Overall 
knowledge of the ACP process will be increased with the implementation of this 
intervention.  Patients will experience a greater quality of life at the end-of-life, care 
congruent with their wishes, and a more dignified dying process with ACP.  Patients with 
CKD will feel more prepared for the road that lies ahead and will be able to decide for 
themselves what they want for their last few days.  This health care organization’s values 
of courage, passion, and family were met with the implementation of an ACP 
intervention specific to those with CKD.   
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Chapter 4 
Findings 
Introduction  
 All data collected for this project was gathered electronically and was de-
identified to maintain patient confidentiality.  Comparison data was collected from 
January 1, 2016 to March 31, 2016.  The comparison sample included patients with CKD 
stages four and five who were seen by the nephrology NP during this time period.  The 
intervention detailed above was implemented from January 1, 2017 to March 31, 2017.  
Despite the great need identified in the literature review for this project, patients who 
were eligible for the intervention were not willing to actively participate in an ACP 
discussion.  Demographic data were collected on patients with CKD stages four and five 
who were seen in the clinic setting by the same nephrology NP who met project criteria 
to receive the intervention.  Demographic data is discussed below and detailed in pie 
chart images.  The greatest area demonstrating change with this intervention was clinical 
significance and this will be discussed in detail below.      
Demographics  
 Various demographic data were collected on both the comparison sample and 
eligible intervention sample populations.  These included age range of the patient, gender 
of the patient, race of the patient, and stage of CKD.  Age ranges were divided into 18-29 
years, 30-49 years, 50-69 years, 70-89 years, and 90+ years.  Possible gender choices 
were male or female.  Races sampled included African American, Caucasian, and Native 
American.  Finally, eligible stages of CKD were stages four and five based on GFR.  
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Information on whether the patient had an existing AD document was also collected for 
both the comparison sample and eligible intervention sample.         
 Comparison data.  The comparison sample consisted of 10 patients.  One patient 
was between 30-49 years of age, four patients were between 50-69 years of age, three 
patients were between 70-89 years of age, and one patient was older than 90 years of age.    
 
Figure 4. Age range of comparison sample of patients seen in the clinic setting by the 
nephrology NP between January 1, 2016 to March 31, 2016.   
  
 Both males and females were equally represented in the comparison sample.  Five 
males and five females with CKD stages four and five were seen in the clinic setting by 
the nephrology NP between January 1, 2016 to March 31, 2016.   
Comparison Data: Age Range 
18-29 30-49 50-69 70-89 90+
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Figure 5. Gender of comparison sample of patients seen in the clinic setting by the 
nephrology NP between January 1, 2016 to March 31, 2016.   
 
 All of the comparison sample patients were of the Caucasian race.  
  
 
Figure 6. Race of comparison sample of patients seen in the clinic setting by the 
nephrology NP between January 1, 2016 to March 31, 2016.   
 
Comparison Data: Gender
Male Female
Comparison Data: Race
African American Caucasian Native American
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 The comparison sample included patients with CKD stages four and five.  CKD 
stage four was more common with seven patients.  CKD stage five was less common 
with three patients.   
 
Figure 7. Stage of CKD of comparison sample of patients seen in the clinic setting by the 
nephrology NP between January 1, 2016 to March 31, 2016.  
 
 The comparison sample patients included both those with and without an existing 
AD document.  Five patients had an existing AD document and five did not.    
 
Comparison Data: Stage of CKD
Stage 4 Stage 5
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Figure 8. Patients of comparison sample with an existing AD document who were seen in 
the clinic setting by the nephrology NP between January 1, 2016 to March 31, 2016.  
 
 None of the patients who were part of the comparison sample had a documented 
ACP discussion in their electronic medical record.   
Intervention data.  The intervention sample consisted of 14 patients who were 
identified as having CKD stages four or five and by having a scheduled appointment with 
the nephrology NP between the time period of January 1, 2017 to March 31, 2017.  Two 
patients were between 30-49 years of age, five patients were between 50-69 years of age, 
and seven patients were between 70-89 years of age.   
Comparison Data: Existing AD Document
No Yes
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Figure 9. Age range of patients eligible for the intervention sample seen in the clinic 
setting by the nephrology NP between January 1, 2017 to March 31, 2017.   
 
 The intervention sample consisted of seven males and seven females.  
 
Figure 10. Gender of patients eligible for the intervention sample seen in the clinic 
setting by the nephrology NP between January 1, 2017 to March 31, 2017. 
 
Intervention Data: Age Range
18-29 30-49 50-69 70-89 90+
Intervention Data: Gender
Male Female
ADVANCE CARE PLANNING                                                                                      70 
  
 A wide variety of races was represented in those eligible for the intervention 
sample.  A majority of the sample were Caucasian (11 patients), two patients were Native 
American, and one patient was African American.   
   
Figure 11. Race of patients eligible for the intervention sample seen in the clinic setting 
by the nephrology NP between January 1, 2017 to March 31, 2017.  
 
 CKD stages four and five were both represented in those eligible for the 
intervention sample.  Ten patients were identified as having CKD stage four.  Four 
patients had CKD stage five.   
 
Intervention Data: Race
African American Caucasian Native American
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Figure 12. Stage of CKD of patients eligible for the intervention sample seen in the clinic 
setting by the nephrology NP between January 1, 2017 to March 31, 2017. 
 
 Finally, of the patients with CKD stages four and five who were seen in the clinic 
setting by the nephrology NP during the intervention period between January 1, 2017 to 
March 31, 2017, seven had an existing AD document and seven did not.  However, these 
seven individuals without an existing AD document declined to participate in the 
intervention for reasons discussed below.   
 
Intervention Data: Stage of CKD
Stage 4 Stage 5
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Figure 13. Patients eligible for the intervention sample who were seen in the clinic 
setting by the nephrology NP who had an existing AD document between January 1, 
2017 to March 31, 2017. 
  
Results   
Clinical significance.  The greatest impact of this project rests in its clinical 
significance.  The DNP Project coordinator conducted regular check-ins with the 
nephrology NP and other members of the clinic staff throughout the course of the project.  
Halfway into the intervention period, despite the inability to successfully recruit patients 
to participate in the project, the nephrology NP identified her approach to her clinical 
practice was changing.  The nephrology NP had been taking time in her routine office 
visits to verify that a patient had an existing AD document, even though this was already 
completed by the nursing staff.  Although half of the patients the nephrology NP saw 
with CKD stages four and five during the intervention period had an existing AD 
document, she was able to take a few minutes to discuss with the patients and individuals 
present at the time of the appointment what the process of ACP was, why it was 
Intervention Data: Existing AD Document
No Yes
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important, and also why it is considered to be a process that is never truly completed.  
The nephrology NP encouraged all patients, both those with and without an AD 
document, to think about addressing their end-of-life needs with those who are closest to 
them.  If a patient had developed an AD document a few years ago, the nephrology NP 
also stressed the necessity of revisiting this document on a regular basis, ensuring what 
he or she wanted at the end-of-life was still accurate and consistent with his or her health 
and disease process.  Although patient knowledge was unable to be directly assessed with 
this intervention due to a lack of active patient participation, many patients were provided 
with basic knowledge of the ACP process.  This is only projected to increase as the 
number of providers who are exposed to this process increases and as patients are offered 
more ACP education.     
The nephrology NP discussed this project with several of the other providers in 
the practice throughout the three month intervention period.  Most of the other providers 
have realized the necessity of this intervention and do want to be able to integrate ACP 
into the care of all of their patients but have not adopted this practice routinely.  The 
nephrology NP had provided education to other providers on ways to bring up these 
sensitive topics with patients and key points patients with CKD need to consider in their 
end-of-life care using the intervention tool developed for this DNP Project.  This project 
did not show statistical significance.  However, the clinical significance and the 
knowledge gained by the nephrology NP and other clinic providers demonstrated how 
beneficial ACP is and how patients will routinely be exposed to and offered ACP at all of 
their office visits with each of their providers.   
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Statistical significance.  Fourteen patients were identified as having CKD stages 
four and five during the intervention period and were scheduled to be seen by the 
nephrology NP during the implementation of this DNP Project.  Half (seven) of these 
patients had an existing AD document and per the institution request, were ineligible to 
receive the developed intervention.  The other seven patients declined to participate in the 
intervention for a variety of reasons.  Discussion with the nephrology NP highlighted a 
few of these reasons, including not seeing the need to develop an AD document, having 
never heard of ACP, and also not wishing to discuss this sensitive issue at the 
appointment.  The unpaired and paired t-tests and detailed statistical analysis were unable 
to be completed with the lack of patient participation in the developed intervention.  It 
was also noted all patients that were identified to have CKD stages four and five who 
were scheduled to see the nephrology NP had never participated in an ACP discussion.  
This demonstrates the need to continue to introduce these patients to ACP and to educate 
these patients about the necessity of a continuous ACP discussion with health care 
providers and family members.   
Summary  
 A lack of eligible and consenting patients was a major barrier to achieving 
statistically significant results with this DNP Project.  However, the clinical significance, 
most notably the increased awareness of the nephrology NP and other clinic providers 
and the initial education of the process of ACP with patients with CKD stages four and 
five, was the greatest success of this project.  Together, these two areas will help to 
further transform the topic of ACP in research and practice and will provide health care 
providers with a way to address ACP with their patients.   
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Chapter 5  
Conclusions 
Discussion of Outcomes  
 This project aspired to achieve many outcomes, including increasing the number 
of patients participating in an ACP discussion, increasing the number of patients 
completing the intervention tool, and increasing knowledge of the ACP process.  These 
outcomes were unable to be directly assessed due to not having any participants in the 
intervention sample.  Statistical analysis could not be run with this project and these 
results were not achieved.   
 The clinical significance of this project, however, indicates this intervention was 
successful in other areas.  The development of a standardized intervention that enabled all 
providers to adopt this process into their practice and also an increase in overall provider 
knowledge were two outcomes achieved with this project.  The nephrology NP for this 
project has now made it a routine practice in all of her clinic visits to ask patients whether 
or not they have an AD document, even if this was already completed by the nursing 
staff.  The clinical practice of the nephrology NP has greatly changed since the beginning 
of this project and this practice has continued despite the end of the project.  Today, in 
addition to asking each patient if they have an AD document, the nephrology NP is also 
asking the patients when this document was last updated, if they have had any major 
changes to their health since this time, and if they are satisfied with the choices they 
made previously.  Each patient is educated on the necessity of revisiting this document on 
a regular basis and discussing what is listed in this document with those who are closest 
to them to ensure their wishes at the end-of-life are carried out as they desire.     
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 Other providers in the same clinic setting are also beginning to use ACP with 
many of their patients, regardless of the patients’ stage of CKD.  The nephrology NP has 
been a great resource for all of the other providers and has started to have discussions 
with each of them as to how her own clinical practice is changing and how she is slowly 
beginning to see a change in the attitude of her patients.  Even though this project did not 
show the great need to continue ACP in this patient population, the changing practice of 
the providers shows how this practice can be incorporated into the care of all patients 
with CKD.  This intervention provides a written starting point for all providers in all 
patient care settings.  This process may be utilized more often and may produce 
achievable and significant results as more patients are exposed to the process of ACP and 
are asked about their AD document on a regular basis.   
Limitations 
 The lack of patients included in this project sample was the biggest limitation for 
this project and greatly hindered the ability to achieve statistically significant results.  It 
was identified by the DNP Project coordinator and the nephrology NP that there were no 
participants in the intervention sample halfway through the intervention period.  The 
DNP Project coordinator contacted the Nursing Research Council of the health care 
institution at which this project was implemented under the guidance of the DNP Project 
advisor.  This was done because prior to implementation of the DNP Project, the Nursing 
Research Council requested that the intervention sample did not include patients who 
already had an existing AD document.  Information was provided to the Nursing 
Research Council regarding the lack of eligible participants and the desire to include 
patients with pre-existing AD documents.  The Nursing Research Council approved the 
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request to continue the intervention and to include those with existing AD documents for 
the remainder of the intervention period.  Together, the DNP Project coordinator, the 
DNP Project advisor, and the nephrology NP decided to include those patients with CKD 
stages four and five with an existing AD document in the last three weeks of the pre-
determined implementation period.  Even despite these changes, patients did not agree to 
participate in the intervention.  The nephrology NP was very flexible in the 
implementation of this project and enabled the clinical significance to be achieved.  This 
project could have easily become stagnant and changes could not have occurred during 
the three month intervention period without the nephrology NP.  The nephrology NP’s 
willingness and desire to incorporate ACP into the routine care of patients with CKD 
allowed clinical significance to occur.    
 The informal letter of invitation, informed consent form, pre- and post-
intervention knowledge assessment document, and discussion tool all had a very high 
readability level.  If these documents were to have been used, this would have been a 
great limitation to this project.  For some persons, it may have been difficult to read and 
complete the documents and actively participate in the intervention for this reason.  More 
time would have been necessary to ensure the patients could understand what they were 
being asked to decide upon.  This limitation would have need to have been considered 
when working with patients with a lower education level.  Reading the documents and 
questions to the patient by the nephrology NP or a family member would have been one 
way to overcome this and still allow the patient to decide upon accurate goals for his or 
her end-of-life care.     
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 Other than the initial meeting held prior to the beginning of the project, the DNP 
Project coordinator had little interaction with the nursing staff.  The individuals rooming 
the patients were not trained in the use of ACP and in ways to approach this topic with 
this patient population.  This fact could have limited the number of willing participants.  
This is an important factor to consider in future projects of this type.       
 This exact project is not continuing at this clinical practice site at this time but all 
of the providers, especially the nephrology NP, are aware of the need for this practice and 
are routinely investigating the AD status of each patient and also continuing to educate 
each patient on the need to revisit and address these documents on a regular basis.  The 
process of ACP is not a one-time process but instead is continuous and must be revisited 
on a regular basis, as was supported in the literature review.  The TTM would help to 
guide providers implementing this intervention to help them identify what stage of 
change the patient is in.  Patients in the precontemplation stage should be targeted with 
education about the process of ACP and why it is important to one’s end-of-life care.  
Once the patient has transitioned to the contemplation and preparation stages, the actual 
process of ACP can then be implemented.  This project confirms this evidence and with a 
longer time frame for this project, more significant results could be achieved and patients 
could agree to participate in the intervention.   
Impact on: 
Organization.  The clinical significance achieved with this project was in line 
with the vision and three core values of the health care institution where this project was 
implemented.  The clinical practice of the nephrology NP has been expanded to include a 
review of the AD status of each patient seen in the clinic setting.  The nephrology NP 
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believes this process will continue in her personal practice.  Both courage and passion are 
qualities she has embodied since this project began.  It is necessary to be willing to step 
outside one’s comfort zone as a provider utilizing courage and passion to provide well-
rounded care for patients with a chronic disease.  The family value of this organization is 
also met while talking with patients who already have an AD document and determining 
if it is recent or if the patient would like to make changes to it.   
Various organizational members were not enlisted to help disseminate these 
results due to the lack of patient participation in this DNP Project.  Once results are 
obtained that show the statistical significance of this project, these persons will help 
gather the support of other providers and patients in other settings.  Education should 
continue and providers should revisit developed ADs with their individual patient 
populations as changes are made.  The more routine the process becomes, the more 
results that can be achieved.        
Finances.  The nephrology NP did spend a few more minutes with each patient 
than she would have normally making sure each patient with CKD stages four and five 
had an existing AD document and changes were not needed, even though intervention 
tools and ADs were not completed during the implementation period of this project.  
There were no direct cost increases with this initial project.  However, as future projects 
are completed and more patients and providers are enlisted to participate in ACP, more 
time may be required to spend with the patients completing the intervention tool.  The 
financial impact should continue to be addressed with the use of any type of ACP 
discussion.  Providers should continue to be made aware of the ability to provide this 
service to all Medicare patients and to use the diagnoses codes that are also available.  
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Medicare and other insurance companies do see the necessity of ACP and it should be 
translated to all health care areas and all patient populations.    
If patients would have participated in the intervention and in the long run, a great 
financial savings would have occurred for the health care institution.  Nicholas et al. 
(2011) showed those with ADs spent over $100,000 less on end-of-life care.  This cost 
savings could override any increased costs that may occur with the implementation of 
this program, such as increased provider time spent with patients actively participating in 
an ACP discussion.  This would be an important factor to consider when choosing to 
implement an ACP discussion in future settings and with other patient populations.          
Policy decisions.  The number of individuals participating in this project was less 
than anticipated.  Currently, changes in policies or procedures have not occurred in this 
health care institution.  The need for this change may be great as more providers are 
made aware of the clinical significance of this project and the need for all individuals 
with CKD to participate in ACP.  Key organizational leaders will need to be enlisted to 
help adopt and implement this change throughout the entire organization, including both 
the inpatient and outpatient settings, once this project has shown to be successful with 
increased participation and with statistical significance.   
Quality of health care.  It was hypothesized that patients with CKD would 
benefit the most from an intervention of this type.  However, this did not occur due to a 
lack of patient participation.  The nephrology NP had the greatest amount of change in 
clinical practice and is now implementing an AD discussion with each of her clinic 
patients.  The provider is still talking with the patient and determining when the last 
updates were made and what the patients’ desire is for his or her end-of-life care even if 
ADVANCE CARE PLANNING                                                                                      81 
  
the patient has an existing AD document.  This discussion, despite not using the 
developed intervention tool, did help to establish a better connection between the patients 
and family members who partook in this process.  Its use will only continue to expand, 
cost savings may result for the health care institution, and policy changes can be made as 
more providers and patients are made aware of this process.   
Direct patient and family member benefits were not able to be successfully 
measured with this project.  This should be the focus of future research and similar 
projects.  It is still anticipated patients will benefit from a higher quality of care 
experienced at the end-of-life, a care that is congruent with their wishes at the end-of-life, 
lower cost of care at the end-of-life, fewer hospitalizations and emergency department 
visits, and an enhanced relationship with their health care provider.  Family member 
benefits may include less stress and anxiety about end-of-life decision making and 
increased confidence caring for his or her family member who has developed an AD or 
participated in ACP.        
Rural or underserved populations.  This project enabled patients from a variety 
of settings the opportunity to participate in ACP.  Regardless of what community the 
patient lived in or how far he or she traveled to be seen in this outpatient clinic, each 
patient meeting the inclusion criteria was offered the ability to complete the intervention 
tool and formulate an advance care plan with the help of his or her family members, 
caregivers, or the nephrology NP.  Patients from a rural setting will experience an 
enhanced awareness of services and options and can formulate an AD document stating 
their exact wishes and desires for their end-of-life care as adjustments are made to this 
project and as it continues to move forward.     
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 Again, as more patients participate and are allowed to formulate an advance care 
plan, informed patients may choose to forgo more expensive, extensive, or invasive 
procedures knowing many of these options may be unsuccessful long-term and may 
result in unnecessary and higher medical costs.  Education of eligible and consenting 
patients remains a key component of the essential use of ACP.  It is hoped that as ACP 
continues to be utilized in all patients with chronic disease, those of rural and 
underserved populations will experience an enhanced quality of life.   
 It was anticipated that non-English speaking patients would be included as part of 
this project’s sample.  However, non-English speaking patients were not seen during the 
three month implementation period.  Language barriers should not be a reason to forgo 
implementing ACP in this population.  It is still essential to provide these patients with 
this service, even though more time will be needed to allow for translation and to ensure 
adequate understanding of the process of ACP.  ACP, even in non-English speaking 
patients, will result in informed and educated patients who are able to access the health 
care system successfully at the end-of-life.      
New Evidence Generated for Practice   
 The literature review completed identified several gaps that were addressed with 
this DNP Project.  A lack of eligible and consenting patients with CKD stages four and 
five did, however, greatly limit the amount of sustainable and effective results that could 
be achieved with this project.  The greatest barrier in developing this DNP Project was 
the lack of an available intervention to use in patients with CKD.  Therefore, a new, 
effective intervention was developed for this project.  It does cover some of the most 
basic questions for a patient with CKD who is nearing the more advanced stages and 
ADVANCE CARE PLANNING                                                                                      83 
  
provides a starting point for an ACP discussion.  This document can be used by others 
and provides health care providers a starting point for these difficult discussions.  
More tangible evidence is needed outside of this project to support the use of ACP 
in this patient population.  ACP has shown to be successful in a wide range of patients 
with other chronic diseases but further research still needs to focus on those with CKD.  
Combined with this specific intervention and specific group of patients, a more 
standardized process of communicating and discussing end-of-life issues, needs, and 
treatment options can be addressed in a meaningful manner.        
Recommendations for Future Projects 
The major limitation to this project was the lack of eligible patients included in 
the project sample.  Future research should focus on expanding the number of patients 
who are eligible to partake in an ACP discussion.  This could be done in many ways, 
such as including patients in lower stages of CKD, such as stages two or three, or having 
more providers implement the process of ACP in their clinic settings.  An NP in a 
specialty practice setting, such as nephrology, often sees the less critical or seriously ill 
patients.  Including a physician in addition to a NP or other advance practice provider 
may continue to expand the number of patients who would be eligible to receive this 
intervention.  If, with the help of these changes, patients who are seen in the clinic setting 
with CKD are shown to benefit from the process of ACP, this intervention could then be 
expanded to include patients in the hospital setting and patients with other chronic 
diseases.  The intervention used for this project has not shown to be unsuccessful and 
should be continued. 
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 The length of time of project implementation should also be expanded in future 
projects.  Three months is a relatively short time frame to expect patients to make and 
discuss their end-of-life decisions with their family members, caregivers, or health care 
providers.  A project involving ACP should last a minimum of six months but one year 
would allow for true and successful results to be achieved.  The process of ACP should 
involve a continuous discussion between the patient and health care provider at each 
office visit encountered in the health care system.  The providers who have currently 
been exposed to ACP should continue to use this practice in their daily patient 
interactions, even in those who do not have a chronic health condition.  
Other than the initial meeting before the project implementation, the nursing staff 
rooming the patients received no education in regards to this specific project.  The DNP 
Project coordinator also never witnessed the rooming of a patient and this per chance was 
a limitation to this project as actions and attitudes of the nursing staff in regards to ACP 
were never directly assessed.  As such, future projects should focus on education of the 
all involved parties to ensure these extraneous variables or personal biases are accounted 
for.   
 This project showed a great need to gather qualitative data in regards to why 
patients were declining to participate in the process of ACP.  The literature review 
completed for this project showed a lack of patient knowledge of the process of ACP and 
this was one of the most cited reasons for choosing not to participate in this specific 
intervention.  Patients also suggested they did not see the need to develop an AD 
document or were not ready to make these decisions during their appointment.  These 
reasons did serve as barriers to the developed intervention.  However, this qualitative data 
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also serves to enhance future research in the area of ACP.  This project shows education 
about ACP must be implemented by providers prior to discussing end-of-life issues.  
Once this process of education is completed, the patients will have a better understanding 
of the necessity of ACP and will be more willing to participate in an intervention.  Other 
research projects focusing on ACP should also begin with education in order to achieve 
the greatest outcomes.  This type of data stresses the need to continuously engage patients 
in an ACP discussion, as was also discussed in the literature review.  An advance care 
plan or AD is not something that can be developed in a short time frame and should 
instead be discussed with patients during successive office visits and at each point of 
contact in the health care system.  The end result of improved education and enhanced 
knowledge will greatly enhance patient care at the end-of-life.     
ACP needs to be included early on in the care of a patient with a chronic disease, 
despite the lack of patient participation and the lack of statistical results achieved with 
this project.  All health care providers will need to help prepare their patients for the end-
of-life and support them as they participate in this endeavor as the research continues to 
grow with ACP and as patients continue to be exposed to ACP.  It is the hope that ACP 
will become a routine topic of discussion between health care providers, patients, and 
family members or close friends.    
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Appendix F: Literature Review Methods Table 
Database(s) Searched Search Terms Number of Results Number Retained 
Cochrane Library  advance care 
planning AND 
CKD, advance care 
planning AND 
renal, advance care 
planning AND 
dialysis, Native 
American AND 
culture beliefs 
2 1 
CINAHL, 
EBSCOhost 
advance care 
planning AND 
CKD, advance care 
planning AND 
dialysis, advance 
care planning OR 
advance directive 
AND kidney failure 
OR renal 
insufficiency OR 
dialysis patient OR 
nephrology nursing, 
Native American 
AND culture beliefs 
24 10 
MEDLINE/PubMed advance care 
planning AND 
CKD, advance care 
planning AND 
renal  
59 6 
Ovid advance care 
planning OR 
advance directive 
AND kidney OR 
renal OR chronic or 
end-stage 
16 1 
USPSTF advance care 
planning 
0 0 
AHRQ advance care 
planning, chronic, 
dialysis, renal  
467 2 
Total  568 20 
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Appendix G: Evidence Table 
Citation Level of 
Evidence 
Sample/Setting Participants 
(n) 
Study Design/ 
Purpose 
Intervention Results Comments; 
strengths and 
limitations 
Agency for 
Healthcare 
Research 
and 
Quality. 
(2014).  
IVB Sources were 
extracted 
through 
database 
searches 
(PubMed, 
Google, 
Respecting 
Choices 
Website, 
POLST 
website) from 
January 2012-
December 
2013.   
Not listed in 
the CPG 
CPG developed 
to help achieve 
improvements in 
ACP through 
development of 
evidence-based 
guidelines, to 
assist 
practitioners in 
engaging 
patients in ACP 
discussions, to 
recommend 
interventions to 
address ACP, 
and to focus on 
key components 
of ACP  
NA  Recommendations: 
implement a 
standardized ACP 
process, assist 
patients to use a 
reliable and valid 
ACP tool, help a 
patient revise his or 
her ACP at least 
annually or with a 
significant health 
change, and 
document the 
patient’s goals in 
their medical record.   
CPG appraised 
using the Agree 
II tool – quality 
rating of 4/7.  
Updated version 
of a previous 
guideline.  Not 
specific to 
patients with 
CKD.  Supports 
use of ACP in a 
variety of adult 
patients.         
 
Strengths:  
Multiple key 
recommendations 
listed.  Multiple 
databases 
searched.   
 
Limitations:  
Number of 
extracted sources 
or number of 
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participants was 
not listed.  Not 
listed if views of 
public opinion 
have been 
sought.  Few 
resource 
implications 
discussed.  No 
update procedure 
provided.       
Agency for 
Healthcare 
Research 
and 
Quality. 
(2015); 
Renal 
Physicians 
Associat-
ion & 
American 
Society of 
Nephro-
logy. 
(1999).  
IVB 1,062 articles 
synthesized for 
systematic 
review 
extracted 
through 
database 
searches 
Not listed in 
this CPG 
CPG developed 
to provide 
clinicians, 
patients, and 
family members 
information in 
regards to 
benefits and 
burdens of 
dialysis, to 
systematically 
allow the health 
care provider to 
make individual 
decisions for 
special health 
care 
circumstances, to 
synthesize 
NA Recommendations:  
develop a patient-
physician 
relationship for 
shared decision 
making, fully inform 
patients of their 
diagnosis, prognosis, 
and all treatment 
options, institute 
ACP, if appropriate, 
withhold dialysis in 
individual patients, 
and offer palliative 
care services to 
appropriate patients 
(early on in the 
disease process).   
CPG appraised 
using the Agree 
II tool  - quality 
rating of 5/7.  
Specific to 
patients with 
CKD.  Not 
specific to only 
ACP 
interventions.  
Supports use of 
ACP in patients 
with CKD.  
Updated version 
of a previous 
guideline – 
reaffirmed 1999 
guideline from 
the Renal 
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available 
research, to 
provide a way to 
make ethically 
sound health 
care decisions, 
and to enhance 
understanding of 
processes used to 
initiate or 
withdraw 
dialysis therapy   
Physicians 
Association and 
American 
Society of 
Nephrology.   
 
Strengths:  In-
depth literature 
search 
completed.  In-
depth 
methodology 
listed.   
 
Limitations:  
Conflicts of 
interest not 
addressed.  Few 
costs 
implications 
addressed.  Not 
discussed 
whether public 
opinion was 
sought. 
Amro, O. 
W., 
Ramasamy, 
M., Strom, 
J. A., 
VB Two outpatient 
dialysis 
facilities in 
Boston, MA 
from June 
201 patients 
with ESRD 
receiving 
outpatient 
hemodialysis  
Quality 
improvement 
project to help 
develop an AD 
method that is 
Patients 
identified by 
a nephrologist 
as having a 
short life 
An additional 12 
patients opted for a 
DNR order (p = 
0.01).  An increase 
from 10% to 90% 
Specific to 
patients with 
CKD.  Shows 
importance of a 
face-to-face 
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Weiner, D. 
E., & 
Jaber, B. L. 
(2016).  
2013 to July 
2014 
practical, widely 
applicable, and 
comprehensive   
expectancy 
were invited 
to participate 
in a focus 
group 
encounter 
dedicated to 
ACP.  Face-
to-face 
encounter was 
held during a 
routine 
dialysis run 
and lasted 
from 15 to 60 
minutes.   
was seen after the 
intervention in 
regards to 
completion of an AD 
form (p < 0.001).  
encounter on 
improving AD 
rates.     
 
Strengths:  Large 
sample size.  
Statistically 
significant 
results.  Study 
conducted at a 
time convenient 
for all 
participants.  
Two different 
dialysis settings 
were used.     
 
Limitations:  No 
control group 
used for 
comparison.  
Sample size too 
small to 
determine impact 
of culture or 
religion on AD 
completion or 
DNR orders.     
Artsanthia, 
J., Mawn, 
IIIB Purposive 
sample of older 
30 Thai 
adults with 
Mixed methods 
focus group 
Focus groups 
were held 
Four major themes 
developed: 
Specific to those 
with CKD.  
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B. E., 
Chaiphiba-
lsarisdi, P., 
Nityasu- 
ddhi, D., & 
Triam- 
chaisri, S. 
K. (2011).  
adults living 
with ESRD 
and their 
family 
members. 
Patients were 
between the 
ages of 50 and 
80 years and 
were followed 
at a 
hemodialysis 
clinic in a 
Bangkok 
Hospital. 
Family 
members were 
adults older 
than 20 that 
provided care 
to a person 
with ESRD, 
were relatives 
of a person 
with ESRD, or 
were identified 
as community 
leaders.     
ESRD and 30 
family 
members  
study focusing 
primarily on 
qualitative 
methods to 
explore the 
needs of 
palliative care 
implemented 
with individuals 
with ESRD 
living in 
Bangkok, 
Thailand  
using a 
qualitative 
interview 
guide to 
explore the 
physical, 
emotional, 
and spiritual 
needs of 
patients with 
ESRD and 
associated 
family 
members  
tremendous 
suffering, economic 
consequences, 
inadequate 
community support, 
and concern for the 
future.  These four 
themes display the 
wide range of issues 
facing these patients.  
Reveals the need for 
an in-depth 
palliative care 
approach with these 
patients that 
addresses all of these 
issues.   
Shows the 
importance of 
integrating 
palliative care 
with patients 
with ESRD.  
Reinforced 
cultural 
importance of 
palliative care 
with CKD 
patients.       
 
Strengths:  Small 
focus groups but 
adequate sample 
size for study 
design.   
 
Limitations:  Use 
of purposive 
sampling.  Only 
one 
country/dialysis 
center was used 
in the study.  
Need for further 
research to 
develop themes/ 
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quantitative data 
more with this 
population and 
intervention.      
Bristowe, 
K., 
Horsley, H. 
L., 
Shepherd, 
K., Brown, 
H., Carey, 
I., 
Matthews, 
B., . . . 
Murtagh, 
F. E. M. 
(2015).  
IIIB Two large 
London renal 
centers that 
service 
approximately 
1000 
hemodialysis 
patients at two 
main and 10 
geographically 
dispersed 
satellite units.  
Participants 
were sampled 
by age (<65, 
65 and over), 
time spent on 
dialysis (<12 
months, 12-36 
months, >36 
months), and 
symptom 
burden and 
from 
November 
20 
hemodialysis 
patients, 11 
participants 
were female, 
9 participants 
were male 
Qualitative 
grounded theory 
design that 
aimed to explore 
the experiences 
of people living 
with ESRD 
regarding 
starting dialysis, 
its impact on 
quality of life, 
and their 
preferences for 
future care and 
to explore the 
ACP needs of 
this population 
and the timing of 
this support   
Semi-
structured 
qualitative 
interview that 
occurred 
during a 
routine 
dialysis 
treatment. 
Recruitment 
occurred until 
data 
saturation was 
reached.   
Participants had a 
variety of unmet and 
unaddressed ACP 
needs, including 
fear, grief, denial, 
shortage of 
information 
regarding illness and 
prognosis, and a lack 
of opportunity to 
discuss concerns, 
prognosis, and future 
care.     
Specific to 
patients with 
CKD.  Supports 
the need for 
earlier ACP in 
patients with 
CKD/ESRD.   
 
Strengths:  
Convenient 
location/time for 
all participants.  
Data saturation 
was reached.   
 
Limitations:  Use 
of purposive 
sampling.  Four 
patients died 
during the study.  
Need for greater 
research 
(longitudinal 
studies) to show 
importance of 
ACP and how 
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2011 – 
February 2012 
outcomes change 
with a specific 
intervention.      
Bullock, K. 
(2011).  
IIIA Focus groups 
gathered from 
Black and 
white 
community-
dwelling 
residents 
202 
participants 
(black 
participants n 
= 102, white 
participants n 
= 100) 
Qualitative focus 
group grounded 
theory design to 
promote cultural 
competency in 
end-of-life care 
that included 
extended family 
networks 
Focus groups 
responded to 
guided 
questions 
about 
preferences 
for or against 
end-of-life 
care, control 
and 
autonomy, 
attitudes and 
beliefs about 
death and 
dying, and 
questions in 
regards to 
ADs 
Caucasians were 
more likely than 
African Americans 
to have completed 
an AD, wanted to 
make their end-of-
life care decisions 
independent of 
family members’ 
influence, and 
viewed hospice care 
more positively.  
White older adults 
tended to value 
individualism, 
independence, self-
reliance, and future 
orientation.  African 
Americans tended to 
value collectivism, 
interdependence, 
interconnectedness, 
and present 
orientation.   
Not specific to 
those with CKD.  
Discussed impact 
culture has on 
ACP and 
differences 
between African 
Americans and 
Caucasians.     
 
Strengths:  
Discussed 
reliability of 
cultural beliefs 
scale.  
Theoretical 
saturation was 
reached.  In-
depth statistical 
analysis was 
completed.       
 
Limitations:  
Setting of study 
was never listed 
making it hard to 
generalize the 
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results or apply 
to another 
situation.   
Carrion, I. 
V., Nedjat-
Haiem, F. 
R., 
Martinez-
Tyson, D., 
& 
Castañeda, 
H. (2013).  
IIIC Purposive 
sampling used 
to recruit 
Latina women 
who self-
identified as 
Colombian, 
Mexican, or 
Puerto Rican 
and resided in 
Central 
Florida.  
Participants 
were recruited 
from 
community 
health clinics, 
churches, 
cultural 
centers, and 
cancer support 
groups. 
45 Latina 
women  
Qualitative 
grounded theory 
design to address 
the lack of 
literature 
regarding ACP 
and decision 
making patterns 
among 
Colombian, 
Mexican, and 
Puerto Rican 
women.  This 
study explored 
cultural 
perceptions and 
identified factors 
that facilitated 
ACP completion 
within this 
specific 
population.   
60-90 minute 
in-depth, 
semi-
structured 
interviews 
composed of 
broad and 
open-ended 
questions.  
Interviews 
were 
conducted at 
locations that 
were 
convenient 
for the 
women.   
Four themes 
developed: lack of 
knowledge of ACP, 
a shared decision 
making approach, 
lack of information 
and informal ACP, 
and a key concern of 
decision making.  
While there is a 
disconnect between 
knowledge regarding 
the term ACP among 
these women, 
discussions 
regarding this topic 
still occurred.  These 
women need the 
influence of family 
in their decisions 
and this highlights 
the need for further 
research involving 
their family 
members.  Higher 
levels of education 
point to a larger 
Not specific to 
CKD.  Discusses 
great cultural 
barriers to using 
and 
implementing 
ACP in a 
culturally diverse 
population.  
Stresses need to 
continue to 
educate this 
group to improve 
knowledge and 
AD completion.     
 
Strengths:  Data 
analysis was 
completed in 
both English and 
Spanish.  
Research team 
consisted of both 
English and 
Spanish 
individuals.   
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percentage of 
completion of ADs 
and ACP 
conversations.  The 
number of years one 
has been in the 
United States also 
influences their 
ability to complete 
an AD.    
Limitations:  Use 
of purposive 
sampling.  
Specific to 
Colombian, 
Mexican, and 
Puerto Rican 
women with 
cancer which 
greatly limits the 
generalizability 
of the results.  
Data saturation 
never discussed.  
Validity and 
reliability of 
research methods 
were not 
discussed.       
Collins, 
M., & 
Lehane, E. 
(2013). 
IIIB Convenience 
sample of adult 
patients 
receiving 
hemodialysis 
that attended a 
dialysis unit at 
an acute 
hospital in 
Ireland.  Had 
received 
50 
participants.   
Non-
experimental 
descriptive 
cross-sectional 
study design to 
determine the 
views of Irish 
patients 
receiving 
hemodialysis on 
Pre-defined 
questionnaire 
using closed-
ended 
questions 
with a 5-point 
Likert scale 
response 
In regards to ACP, 
patients wanted 
honest opinions 
from their doctors.  
Patients wanted 
some involvement in 
decision making at 
the end-of-life; 
however, they also 
wanted medical 
interventions to keep 
Specific to CKD.  
Stresses necessity 
of ACP and 
giving patients 
honest opinions 
near the end-of-
life.  Family is 
important to 
these patients as 
they near the 
end-of-life.   
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hemodialysis 
for a minimum 
of three 
months, had to 
be able to read 
and understand 
English, and 
were 18 years 
of age and 
older   
death, dying, and 
ACP   
them around as long 
as possible.  Family 
members play an 
important role in the 
patient’s lives, but 
they are not 
necessarily 
comfortable 
discussing end-of-
life issues with 
them.   
 
Strengths:  
Descriptive 
statistics used to 
summarize 
results.   
 
Limitations:  
Results limited to 
one dialysis unit.  
Results limited to 
patients from 
Ireland.  Further 
statistical 
analysis is 
needed to 
determine the 
significance of 
the results.  
Reliability and 
validity of study 
questionnaire not 
discussed.         
Feely, M. 
A. Swetz, 
K. M., 
Zavaleta, 
K., 
Thorstein- 
IIA Adult patients 
18 years of age 
and older who 
received 
hemodialysis 
at a single 
outpatient 
91 patients 
participated 
in specialist 
palliative 
medicine 
consults  
Quasi-
experimental 
study to 
determine the 
feasibility of 
embedding 
palliative 
Specialist 
palliative 
medicine 
consultations 
performed by 
two board-
certified 
Patients were well-
receiving of these 
discussions and 
preferred to 
complete them 
during dialysis.  
After intervention, 
Specific to those 
with CKD.  
Shows 
importance of 
palliative 
medicine 
consults.  
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sdottir, B., 
Albright, 
R. C., & 
Williams, 
A. W. 
(2016).  
center between 
January 1, 
2012 and June 
30, 2012 
medicine 
consultations 
into the 
outpatient 
hemodialysis 
setting and to 
determine the 
impact of this 
intervention on 
ACP and 
symptom 
management   
physicians 
and occurred 
during a 
routine 
hemodialysis 
run.  A chart 
review was 
completed 
both before 
and after the 
intervention 
to determine 
documented 
ADs, code 
status, and 
goals of care.   
54 patients had a 
documented goals of 
care discussion (p < 
0.0001).  Number of 
patients electing a 
full code status 
increased after the 
intervention (p < 
0.0001).   
Effective if 
implemented 
during 
hemodialysis 
treatments.   
 
Strengths:  Large 
sample size.  In-
depth statistical 
analysis 
completed.  
Discussed 
validity and 
reliability of 
measures used.    
 
Limitations:  
Purposive sample 
used.  Study took 
place at only one 
hemodialysis 
center.  No 
control group.  
Lack of 
randomization.     
Goff, S. L., 
Eneanya, 
N. D., 
Feinberg, 
R., 
IIIB Purposive 
sampling from 
dialysis units 
in 
Massachusetts 
13 patients 
and 9 family 
or friends 
were 
interviewed 
Qualitative 
grounded theory 
design to 
investigate how 
dialysis teams 
Interviews 
conducted by 
study team 
members.  
Interviews 
Three emerging 
themes: prior 
experiences with 
ACP, factors that 
may affect 
Specific to CKD.  
Involved both 
patients and 
family members.  
Study identified a 
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Germain, 
M. J., 
Marr, L., 
Berzoff, J., 
. . . Unruh, 
M. (2015).  
and New 
Mexico.  
Participants 
were invited to 
bring up to two 
family 
members or 
close friends to 
also 
participate.   
during 15 
sessions  
should discuss 
ACP 
were 
conducted 
until 
theoretical 
saturation was 
reached.   
perspectives with 
ACP, and 
recommendations 
for ACP.  Themes 
revealed that ACP 
discussions rarely 
occur yet most 
patients and families 
desire them, patients 
desire a better 
connection with 
their nephrology 
team, and that health 
care providers 
should lead ACP 
discussions at least 
annually.   
need for an 
interview guide 
specific to 
dialysis patients 
or those with 
CKD.    
 
Strengths:  
Interviews were 
conducted until 
theoretical 
saturation was 
reached.  Validity 
of interview 
guide was 
assessed prior to 
implementation.     
 
Limitations:  
Although 
theoretical 
saturation was 
reached, the 
small sample size 
might have 
prevented 
additional themes 
from being 
exposed.  
Interviews were 
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conducted in 
only two states, 
which may limit 
the 
generalizability 
of these results.     
Harrison, 
K., & 
Watson, S. 
(2011).  
IIB Recruited from 
a nephrology 
clinic.  Patients 
had previously 
chosen 
conservative 
management 
for CKD or 
were in need of 
decision-
making 
support.  Clinic 
took place in a 
renal satellite 
hospice unit 
during October 
2008 – October 
2009.   
18 patients 
were seen for 
a total of 50 
consultations 
over the time 
period of one 
year  
Quasi 
experimental 
design to 
investigate the 
effects of a 
nurse-led 
palliative care 
clinic on patients 
with CKD stage 
five and their 
carers 
Nurse-led 
monthly 
educational 
palliative care 
clinic (led by 
a hospice 
nurse and a 
renal 
palliative care 
nurse) aimed 
to provide 
optimal 
symptom 
management, 
empower 
patients to 
make their 
own choices, 
and to support 
them in ACP 
Patients found the 
clinic to be helpful 
to help appropriately 
manage the 
underlying condition 
and symptoms with 
a continuity of care.  
Patients were 
exposed to palliative 
care earlier on in the 
disease process than 
commonly occurs.  
Patients felt 
supported, had an 
opportunity to make 
ACP decisions with 
family present.  
Family caregivers 
reported a better 
understanding of the 
disease, felt more 
prepared for the 
future, and less 
anxious.   
Specific to CKD.  
Generally the 
clinic was well-
evaluated.  
Involved patients 
both before 
dialysis initiation 
and while 
receiving dialysis 
therapy.  
Involved patients 
and family 
members.       
 
Strengths:  75% 
of surveys were 
completed after 
the intervention.   
 
Limitations:  
Small sample 
size.  Six patients 
died during the 
course of the 
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study.  Statistical 
analysis of study 
results not shown 
or discussed.  
Validity and 
reliability of 
intervention and 
post-survey not 
discussed.              
Kataoka-
Yahiro, M. 
R., 
Yancura, 
L. A., 
Page, V., & 
Inouye, J. 
(2011).  
IIIB Purposive 
sample of 
Asian-Pacific 
Islanders 
recruited from 
a dialysis 
center located 
in Oahu, HI.  
Had to be 
family 
caregivers for 
patients 
receiving 
hemodialysis 
for CKD stage 
four and stage 
five.  Data was 
collected 
between May 
2009 and 
14 Asian-
Pacific 
Islander 
family 
caregivers of 
persons 
receiving 
hemodialysis  
Qualitative 
grounded theory 
study design to 
describe the 
attitudes, 
subjective 
norms, and 
perceived 
behavioral 
control among 
Asian-Pacific 
Islander family 
caregivers of 
those receiving 
hemodialysis for 
CKD stage four 
and stage five  
Four focus 
group 
sessions held 
at the dialysis 
center that 
lasted one 
hour to 90 
minutes.   
Completion of ACP 
and ADs are 
associated with 
peace of mind and 
ease of making 
future decisions.  It 
also prevents 
burden, minimizes 
family disputes, and 
allows family 
members to see 
problems ahead of 
time.  Most family 
members desired to 
feel comfortable 
with ACP and ADs 
so that they were 
able to carry out 
patient wishes and 
not be a burden to 
his or her family.  
Specific to CKD.  
Discussed 
benefits of ACP 
on family 
members.  Shows 
necessity of 
involving family 
members in ACP 
and end-of-life 
care, especially 
in the Asian-
Pacific Islander 
population.     
 
Strengths:  Data 
was collected 
until theoretical 
saturation was 
reached.  Two 
authors read and 
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September 
2009.       
Family is first and 
primary in decision 
making.     
analyzed focus 
group transcripts.   
 
Limitations:  
Purposive sample 
used from one 
dialysis center.  
Sample taken 
from one state.  
Need for more 
quantitative 
research in this 
area to determine 
true cultural 
barriers and 
resource 
implications.  
Validity and 
reliability of 
focus group 
questions not 
discussed.   
Kirchhoff, 
K. T., 
Hammes, 
B. J., Kehl, 
K. A., 
Briggs, L. 
A., & 
IIC Two health 
centers in 
Wisconsin 
with associated 
clinics and 
dialysis units 
153 
participants 
in the control 
group (64 
with ESRD, 
90 with 
CHF).  160 
participants 
Quasi 
experimental 
post-test only 
design to 
compare patient 
preferences for 
end-of-life care 
with care 
Patient 
centered ACP 
interview 
with patient 
and family 
members 
lasting 
between one 
In CPR, 43.5% of 
the intervention 
patients had 
outcomes matching 
their initial 
preferences.  
However, almost 
one-third of patients 
Study not 
specific to 
patients with 
CKD.  Involved 
patients and 
family members.  
Results indicate 
that intervention 
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Brown, R. 
L. (2012).  
in the 
intervention 
group (70 
with ESRD, 
90 with 
CHF).  
Patients and 
family 
members 
were 
recruited as 
pairs.     
received at the 
end-of-life   
and one and a 
half hours.   
changed their mind 
about CPR 
preferences.  For 
patients with ESRD, 
more intervention 
patients than control 
(37.7% versus 17%) 
chose to withdraw 
from dialysis.   
patients may 
choose fewer 
life-sustaining 
interventions 
near the end-of-
life, but the 
differences were 
not shown to be 
statistically 
significant.     
 
Strengths:  Study 
looked at patients 
with two 
common chronic 
illnesses.  Post-
test only study 
design used to 
determine effect 
of intervention.     
 
Limitations:  
Potential effects 
of the study 
could have been 
reduced due to 
patient death 
(110 patients 
died before the 
end of the study).  
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Study was 
completed only 
in one state and 
involved only 
those with ESRD 
and CHF (great 
limit on 
generalizability).  
Statistical 
analysis of study 
results not shown 
or discussed.  
Validity and 
reliability of 
intervention not 
discussed.            
Luckett, T., 
Sellars, M., 
Tieman, J., 
Pollock, C. 
A., 
Silvester, 
W., Butow, 
P. N., . . . 
Clayton, J. 
M. (2014). 
IB 55 articles 
reporting on 51 
discrete 
samples 
included (7 
intervention 
records, 48 
other records).  
Sample 
included adults 
with CKD 
and/or families 
caring for this 
group of 
Not listed in 
the meta-
synthesis  
Meta-synthesis 
using both 
quantitative and 
qualitative 
designs to 
identify what 
interventions 
have been 
developed, 
piloted, and 
evaluated in 
regards to ACP 
in patients with 
CKD, to identify 
Studies used a 
variety of 
methods – 
teaching 
sessions, 
videos, 
telephone 
interviews, 
printed 
materials, and 
face-to-face 
education 
with 
physicians.   
Two studies found 
ACP to have a 
significant effect on 
both patient-
clinician 
communication and 
interaction.  One 
study increased AD 
completion rates.  In 
one study, 76% of 
nephrologists were 
in favor of an ACP 
intervention while 
70% of patients 
Specific to CKD.  
Both qualitative 
and quantitative 
studies were 
included in this 
review.  This 
study was the 
first meta-
synthesis to focus 
on ACP in those 
with CKD.  
Findings were 
not found to be 
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patients (44 
articles 
involved 
patients with 
CKD and 6 
articles 
involved 
families/care- 
givers).  All 
patient samples 
included 
people with 
CKD stage 5 
and 2 articles 
included 
patients with 
CKD stage 4.        
5 articles took 
place in the 
inpatient 
setting while 
24 articles 
involved the 
outpatient 
setting.  35 
articles took 
place in the 
United States.   
what measures 
have been used 
in intervention 
and other 
research studies, 
to establish 
evidence for the 
efficacy of 
interventions, 
and to inform 
understanding of 
barriers and 
facilitators to 
implementation 
of ACP.   
found an AD 
pamphlet helpful.  
No studies found a 
significant effect for 
patient/surrogate 
decisional conflict.  
However, two 
studies found a 
significant effect for 
congruence between 
patient wishes and 
surrogate knowledge 
of those wishes after 
an ACP intervention.   
significant across 
multiple studies.     
 
Strengths:  
Comprehensive 
approach to ACP 
that focused on 
patient, 
caregiver, and 
system related 
factors.  Most 
research in 
regards to ACP 
and CKD has 
been descriptive 
in nature and this 
meta-synthesis 
followed this.     
 
Limitations:  Key 
search terms 
were not listed in 
the study 
description.  Data 
extraction was 
completed by 
only one 
researcher.  No 
studies included 
measured 
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compliance with 
patient wishes for 
end-of-life care.  
Only one 
intervention 
study 
demonstrated the 
effect on patient 
and family 
outcomes.  None 
of the 
intervention 
studies looked at 
the effect of ACP 
on bereaved 
family members.    
Nicholas, 
L. H., 
Langa, K. 
M., 
Iwashyna, 
T. J., & 
Weird, D. 
R. (2011).  
IIIA Health and 
Retirements 
Study 
respondents 
who died 
between 1998 
and 2007 at 
age 65 years or 
older after 
qualifying 
through 
Medicare 
through 
disability or 
3302 
decedents  
Non-
experimental 
descriptive 
cohort study to 
examine the 
relationship of 
ADs with the 
cost and 
aggressiveness 
of end-of-life 
treatment in the 
United States 
Post-mortem 
interview 
conducted 
with next-of-
kin.  Asked 
about the 
decedent’s 
experience at 
the end-of-
life, including 
the nature and 
type of their 
AD.  Chart 
review 
Those with 
treatment-limiting 
ADs had lower rates 
of life-sustaining 
treatments (p = 
0.02), lower rates of 
in-hospital death (p 
< 0.01), and higher 
rates of hospice use 
(p < 0.01).  Those 
with ADs were more 
likely to be white, 
affluent, and highly 
educated.  Decedents 
Not specific to 
CKD but does 
discuss those 
with ESRD. 
 
Strengths:  Large 
sample size.  
Studied Medicare 
decedents 
throughout the 
United States.  
Large amount of 
statistical 
analysis.     
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ESRD.  Had to 
be enrolled in 
fee-for-service 
Medicare 
during the last 
six months of 
life 
calculated 
Medicare 
spending in 
the last six 
months of life 
across all care 
settings 
residing in low-
spending regions 
were more likely to 
have treatment 
limiting ADs (p < 
0.01).  End-of-life 
spending was lower 
for decedents in low-
spending regions 
than those in higher 
spending regions.   
 
Limitations:  
Non-
experimental 
design limits 
ability to 
determine casual 
effect.   
 
Oczkowski
, S. J., 
Chung, H., 
Hanvey, 
L., 
Mbuagbaw
, M., & 
You, J. J. 
(2016).  
IA 67 articles 
obtained from 
studies 
conducted in 
the ambulatory 
setting 
(included 47 
qualitative 
only studies for 
future review, 
19 ICU-based 
studies, 18 
inpatient, non-
ICU studies, 
and 20 
educational 
studies) 
Not listed in 
this meta-
synthesis  
Meta-synthesis 
using both 
qualitative and 
quantitative 
study designs to 
determine the 
effect of 
structured 
communication 
tools for end-of-
life decision 
making on 
completion of 
ADs in the 
ambulatory care 
setting  
Variety of 
interventions 
examined: 
verbal 
discussion 
alone, paper 
tools alone, 
verbal 
discussion 
combined 
with paper 
tool, and 
computer 
programs  
Interventions were 
associated with a 
statistically 
significant increase 
in frequency of ACP 
discussions (p = 
0.007) and 
frequency of 
completion of ADs 
(p < 0.001).  For 
patients who died 
throughout the 
course of the studies, 
the communication 
tools were 
associated with a 
statistically 
significant increase 
in the congruence of 
Not specific to 
patients with 
CKD.  Showed 
great benefits of 
using structured 
communication 
tools to improve 
frequency of 
ACP and 
acceptability of 
these discussions 
with patients and 
family members.  
Looked at the 
effect of ACP 
with family 
members.     
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care desired by 
patients (p = 0.004).  
Communication 
tools reduced 
patient’s desire for 
life-sustaining 
treatments but was 
not statistically 
significant (p = 
0.02).  Knowledge 
of family members 
was enhanced with 
the use of structured 
communication tools 
(p < 0.001).  All 
studies found 
communication tools 
to be equally or 
more acceptable 
than usual care.   
Strengths:  
Involved both 
qualitative and 
quantitative 
studies targeted 
to ACP.  Showed 
importance of 
ACP for patients 
with cancer, lung 
disease, heart 
disease, 
neurologic 
disease, and renal 
disease.  In-depth 
description of 
study 
methodology and 
data extraction 
methods.  Two 
separate authors 
were used to 
screen studies.  
Discussed a wide 
variety of 
interventions to 
use as 
communication 
tools.     
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Limitations:  
Studies limited to 
those in 
ambulatory 
settings.  Even 
despite 
statistically 
significant 
findings, many 
studies were 
found to be of 
low-quality when 
appraised.     
Song, M., 
Ward, S. 
E., Fine, J. 
P., Hanson, 
L. C., Lin, 
F., Hladik, 
G. A., . . . 
Bridgman, 
J. C. 
(2015). 
IB Recruited from 
20 outpatient 
dialysis centers 
in 8 counties in 
North Carolina 
between March 
2010-
December 
2012 
420 
participants 
from 20 
dialysis 
centers.  
Patient and 
family 
members 
were 
recruited as 
pairs 
(intervention 
group n = 
109, control 
group n = 
101) 
RCT that 
examined the 
efficacy of an 
ACP 
intervention on 
preparation for 
end-of-life 
decision making 
for dialysis 
patients and 
surrogates and 
for surrogate’s 
bereavement 
outcomes   
Intervention 
group took 
part in a 
psycho-
educational 
intervention 
(Sharing 
Patient’s 
Illness 
Representat-
ions to 
Increase Trust 
[SPIRIT]).  
SPIRIT 
consists of 
two sessions.  
All sessions 
Congruence in goals 
of care for both 
patients and 
surrogates was 
higher in those who 
participated in the 
SPIRIT intervention 
at two and six 
months, but the 
effect was not 
significant across all 
time points.  Patient 
decisional conflict 
decreased over time 
in those who 
participated in 
SPIRIT (p = 0.01).  
Specific to CKD.  
Involved both 
patients and 
family members.  
Results show that 
patient and 
surrogate 
congruence may 
not be sustained 
over time, which 
shows the need 
for ongoing 
intervention with 
this group.   
 
Strengths:  This 
is the first trial to 
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included both 
patient and 
family 
members.  
Surrogate decision 
making confidence 
scale scores were 
high at all time 
points.  The SPIRIT 
intervention effects 
on congruence and 
surrogate decision 
making confidence 
score were 
statistically 
significant at p = 
0.03 and p = 0.03 
respectively.  
However, the effect 
of dyad congruence 
was significantly 
decreased at 12 
months (p = 0.04) 
for those in the 
intervention group.  
Depression scores in 
those who were part 
of the SPIRIT 
intervention were 
significantly lower 
at 3 months and 6 
months (p = 0.01).     
show effects of 
bereavement 
outcomes of 
surrogates of 
patients with 
ESRD.  This is 
the only RCT to 
demonstrate 
positive effects in 
a sample with 
African 
Americans.     
 
Limitations:  45 
persons died 
during the study.  
Study was 
conducted in a 
single United 
States region.  
Data collection 
methods were not 
clearly described 
in the article.  
Validity or 
reliability of the 
instruments used 
was not fully 
discussed.     
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Waite, K. 
R., 
Federman, 
A. D., 
McCarthy, 
D. M., 
Sudore, R., 
Curtis, L. 
M., Baker, 
D. W., . . . 
Paasche-
Orlow, M. 
K. (2013).  
IIIA Adults aged 55 
to 74 were 
recruited from 
an internal 
medicine clinic 
or one of four 
federal health 
centers in 
Chicago 
between 
August 2008 
and November 
2010.   
784 adults 
were 
included in 
analysis 
(two-thirds of 
the 
participants 
were female)   
Non-
experimental 
descriptive 
correlational 
study design to 
examine the 
effect of the 
relationship 
between literacy 
and other 
individual-level 
factors on having 
an AD  
Face-to-face 
structured 
interviews 
with a trained 
interviewer, 
completed for 
4 hours 
divided over 
2 days 
Literacy skills were 
strongly associated 
with having an AD – 
12.4% with low 
literacy, 26.6% with 
marginal literacy, 
and 49.5% with 
adequate literacy (p 
<0.001).  Race was 
also associated with 
having an AD – 
African Americans 
22.9%, white 57.2% 
(p < 0.001).  Other 
factors associated 
with AD completion 
include older age, 
higher education, 
higher income, part-
time employment, 
and fewer chronic 
health conditions.   
Study not 
specific to 
patients with 
CKD.  Strong 
statistically 
significant 
correlation 
between health 
literacy and 
having an AD.  
Suggests need to 
target the 
population of 
patients with a 
lower health 
literacy.   
 
Strengths:  In-
depth statistical 
analysis 
completed.  
Large sample 
size.  Looked at 
multiple 
variables other 
than just health 
literacy.     
 
Limitations:  No 
reliability or 
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validity of 
interview 
questions 
discussed.  
Participants in 
this study were 
mainly African 
American and 
Caucasian.         
Walton, J. 
(2011).  
IIIB Non-
randomized 
convenience 
sample of 
college 
students.  
Participants 
were primarily 
Caucasian; 
ages ranged 
from 18 to 45 
with a majority 
of the 
participants 
ages 22 years 
and female 
95 college 
students (65 
were enrolled 
in a health 
science 
course from a 
liberal arts 
college in the 
rural 
Northwest; 
30 student 
nurses 
attending a 
Montana 
nursing 
association 
conference) 
Mixed methods 
design involving 
quantitative and 
qualitative study 
designs.  
Quantitative 
component 
involved a pre- 
and post-survey 
to assess if there 
was a 
statistically 
significant 
difference in the 
knowledge and 
cultural 
awareness of 
students 
following an 
educational 
intervention by a 
60 minute 
educational 
presentation 
based on 
research 
findings from 
a study 
entitled 
Prayer 
Warriors: A 
Grounded 
Theory Study 
of American 
Indians 
Receiving 
Hemodialysis 
Students can learn 
cultural awareness to 
Native Americans 
receiving dialysis 
and apply cultural 
interventions 
following an 
educational session.  
Five themes 
emerged from the 
case study findings: 
approaching the 
patient with an open 
mind, assessing 
beliefs and culture, 
educating and re-
educating with the 
patient and family, 
convincing the 
patient to begin 
Specific to 
Native 
Americans with 
CKD.  Shows 
importance of 
cultural 
awareness when 
working with the 
Native American 
culture.  Shows a 
brief educational 
period can 
enhance the 
relationship 
between a patient 
of another culture 
and a health care 
provider.   
 
Strengths:  
Sufficient sample 
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nephrology 
nurse.  
Qualitative 
component 
involved 
students writing 
a reflection 
paper of a case 
study of a young 
Native American 
patient with 
CKD.  
dialysis, and creating 
a sacred space. 
size for the study 
design.  Involved 
two methods of 
assessing cultural 
barriers to 
providing care to 
the Native 
American 
population.  
Intervention was 
based off of a 
prior research 
study.   
 
Limitations:  
Sample 
population was a 
non-randomized 
convenience 
sample of 
students from 
two different 
settings.  Sample 
was primarily 
female and 
around the same 
age.  Pre- and 
post-survey was 
developed from 
the findings of 
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another research 
article.  
Reliability and 
validity of this 
instrument was 
never discussed.   
White, B., 
Tilse, C., 
Wilson, J., 
Rosenman, 
L., Strub, 
T., Feeney, 
R. & 
Silvester, 
W. (2014).  
IIIB National 
sample of the 
Australian 
adult 
population 
(aged 18 and 
above) 
conducted 
between 
August and 
September 
2012 
2405 
individuals 
agreed to be 
interviewed 
with 50% 
being female 
Non-
experimental 
cross-sectional 
descriptive 
prevalence study 
to determine the 
prevalence of 
ADs in the 
Australian 
population 
National 
telephone 
survey  
Only 14% of 
respondents had 
prepared an AD.  
Respondents with a 
financial EPA were 
almost nine times 
more likely to have 
an AD than those 
without.  
Respondents with a 
living will were 2.5 
times more likely 
than those without to 
have an AD.  
Respondents who 
were either single or 
not in a legally 
recognized 
relationship were 1.7 
times more likely 
than those who were 
married to have an 
AD.   
Results not 
specific to those 
with CKD.       
 
Strengths:  Equal 
representation of 
males and 
females.  Diverse 
age of sample.  
In-depth 
statistical 
analysis was 
completed.   
 
Limitations:  
Study was 
completed in 
only one country.  
Low response 
rate to telephone 
survey.  Small 
sample size in 
comparison to 
entire population.  
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Only discussed 
ADs and not 
other legal 
documents.     
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Appendix H: Approval Letter to Use Iowa Model 
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Appendix I: Approval Letter to Use Renal Physicians Association Guideline  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADVANCE CARE PLANNING                                                                                           130 
      
Appendix J: Pre-Intervention Knowledge Assessment 
Advance Care Planning for Patients 
with Chronic Kidney Disease 
Answer the following questions below before your discussion with 
the health care provider.   
1.  An advance directive is a document that: 
o Expresses an individual’s medical wishes when that person is unable to speak 
for him- or herself 
o Determines who will handle one’s financial affairs after death  
o Explains one’s rights as a patient  
o I don’t know 
 
2.  Advance directives go into effect if an individual:   
o Gets admitted to the hospital 
o Has a terminal medical condition 
o Can no longer communicate his or her health care decisions 
o I don’t know 
 
3.  In general, the best person to serve as an individual’s health care surrogate is the person 
who: 
o Has the most knowledge 
o Is best able to represent the individual’s views 
o Has known the individual the longest 
o I don’t know 
 
4.  Of the following, which is least important for a patient to do regarding advance care 
planning? 
o Discuss their values and wishes regarding end-of-life care with trusted family 
members and friends 
o Create an advance directive that explains their goals of care 
o Provide their physician(s) with the advance directive 
o Use a state-specific living will form 
 
5.  Advance care planning is a one-time process and does not need to be revisited during the 
course of a patient’s life.  
o True 
o False 
 
6.  If an individual has decision-making capacity and can still speak for him- or herself, an 
advance directive does NOT determine which medical treatments they will receive.   
o True 
o False 
 
(Adapted from Green & Levi, 2011) 
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Appendix K: Post-Intervention Knowledge Assessment 
Advance Care Planning for Patients 
with Chronic Kidney Disease 
Answer the following questions below after your discussion with the 
health care provider.   
1.  An advance directive is a document that: 
o Expresses an individual’s medical wishes when that person is unable to speak 
for him- or herself 
o Determines who will handle one’s financial affairs after death  
o Explains one’s rights as a patient  
o I don’t know 
 
2.  Advance directives go into effect if an individual:   
o Gets admitted to the hospital 
o Has a terminal medical condition 
o Can no longer communicate his or her health care decisions 
o I don’t know 
 
3.  In general, the best person to serve as an individual’s health care surrogate is the person 
who: 
o Has the most knowledge 
o Is best able to represent the individual’s views 
o Has known the individual the longest 
o I don’t know 
 
4.  Of the following, which is least important for a patient to do regarding advance care 
planning? 
o Discuss their values and wishes regarding end-of-life care with trusted family 
members and friends 
o Create an advance directive that explains their goals of care 
o Provide their physician(s) with the advance directive 
o Use a state-specific living will form 
 
5.  Advance care planning is a one-time process and does not need to be revisited during the 
course of a patient’s life.  
o True 
o False 
 
6.  If an individual has decision-making capacity and can still speak for him- or herself, an 
advance directive does NOT determine which medical treatments they will receive.   
o True 
o False 
 
(Adapted from Green & Levi, 2011) 
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Appendix L: Intervention Tool   
 
Advance Care Planning for Patients 
with Chronic Kidney Disease 
Advance care planning is a communication process that takes place 
between the patient, family member or close friend, and/or the health 
care provider.  The patient’s preferences for future medical care is 
decided.  Read and discuss the questions below with a family 
member, close friend, or health care provider.  Write your wishes on 
the lines below.  Keep a copy for your records and return the 
completed form to a clinic staff member.   
 
o If you become unable to make decisions for yourself, whom do you want to make 
decisions for you? 
_____________________________________________________________________
_____________________________________________________________________ 
 
o If you had to choose between being kept alive as long as possible regardless of 
personal suffering or living a shorter time to avoid suffering and medical procedures 
such as breathing machines and feeding tubes, which would you pick? 
_____________________________________________________________________
_____________________________________________________________________ 
 
o Under what circumstances, if any, would you want to stop dialysis? 
_____________________________________________________________________
_____________________________________________________________________ 
 
o Under what circumstances, if any, would you not want to be kept alive with medical 
means such as cardiopulmonary resuscitation, a feeding tube, or mechanical 
ventilation? 
_____________________________________________________________________
_____________________________________________________________________ 
 
o Where do you prefer to die and whom do you wish to be with you when you die?  
_____________________________________________________________________
_____________________________________________________________________ 
 
(Renal Physicians Association & American Society of Nephrology, 1999; AHRQ, 2015) 
 
Patient Signature: __________________________________   Date: _____________ 
Notary Signature: __________________________________   Date: _____________ 
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Appendix M: Informal Letter of Invitation 
 
Dear patient: 
I, Chelsea Hinders, am conducting a project entitled "Implementation of an Advance 
Care Planning Discussion for Patients with Chronic Kidney Disease" as part of a Doctor of 
Nursing Practice project at South Dakota State University.  The purpose of the project is to 
implement a standardized process of advance care planning specific to patients with chronic 
kidney disease stages four and five in an urban outpatient setting.   
You as a patient are invited to participate in the project by actively participating in a 
discussion during your office visit with a nephrology Nurse Practitioner and completing a 
test before and after the discussion.  We realize that your time is valuable and have attempted 
to keep the requested information as brief and concise as possible. It will take you 
approximately 30 to 40 minutes of your time. Your participation in this project is voluntary. 
You may withdraw from the project at any time without consequence. 
There is minimal risk to you for participating in this study. An advance care planning 
discussion collects information about sensitive goals of care issues and asks questions that 
could possibly cause psychological distress, discomfort, and anxiety beyond what is 
experienced in daily conversation.  As a participant, you will have the option of not 
answering any questions which you find upsetting.   
 The benefits to you include having a document that states your exact wishes for your 
goals of care in your medical record.  Your health care provider and family members or 
caregivers will also be made known of your wishes and will be able to carry out your desires 
should the time arise.  Your responses are strictly confidential.  When the data and analysis 
are presented, you will not be linked to the data by your name, title or any other identifying 
item.  Please assist us in our project and participate in the discussion with the nephrology 
Nurse Practitioner and complete a test before and after the discussion.  
 
Sincerely, 
 
Chelsea Hinders  
nephrologyacp@gmail.com 
605-610-9039 
     
o I agree to participate o I decline to participate  
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Appendix N: Informed Consent Form 
 
Sanford Health  
Consent to Participate in a Study 
 
Title: Implementation of an Advance Care Planning Discussion for Patients with Chronic 
Kidney Disease  
 
Principal Investigator: Chelsea Hinders 
 
What is the purpose of this study?  
The purpose of this study is to implement a standardized process of advance care planning 
specific to patients with chronic kidney disease stages four and five in an urban outpatient 
setting.   
 
What will happen during this study? 
As a participant in the study, you will be participate in a discussion regarding end-of-life 
wishes and care with a Nurse Practitioner.  Your family members and/or those who are with 
you today will also be asked to participate in the conversation.  Five specific questions will 
be used to guide the conversation.  Your answers will be written down and placed into your 
electronical medical record to reference at future appointments and during future 
hospitalizations.  Your answers can be changed at any time and the questions can be 
answered at a future date.  This study will serve as a facilitator of end-of-life discussions and 
will help guide your future health care.       
 
Your participation in the study will last during this office visit only.  No return appointments 
specific to this study will be required.  Participation in the study will take approximately 30 
to 40 minutes of your time.   
 
What are the risks of the study? 
There may be some risk from being in this study but any risk for participating is not expected 
to be more than risk experienced in everyday life.  An advance care planning discussion 
collects information about sensitive goals of care issues and asks questions that could 
possibly cause psychological distress, discomfort, and anxiety beyond what is experienced in 
daily conversation.  As a participant, you will have the option of not answering any questions 
which you find upsetting.      
 
What are the benefits of this study? 
You may not benefit personally from being in this study.  However, we hope that, in the 
future, other people might benefit from this study by having exact end-of-life wishes 
documented clearly in an electronic medical record.  Care at the end-of-life will be enhanced 
and individual patient wishes will be upheld during this difficult time.    
 
What are the alternatives to participating in this study?  
The alternative is to not participate in this study.  
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Are my records confidential? 
While we cannot guarantee absolute confidentiality, we will use all available security 
measures to minimize the risk that this information would be given to someone outside of the 
study.  Your study record may be reviewed by the Sanford Institutional Review Board (IRB) 
and Sanford Research Compliance.  
 
If we write a report or article about this study, we will describe the study results in a 
summarized manner so that you cannot be identified.  Confidentiality will be maintained by 
means of de-identifying personal data.  Any personal information collected will be stored in a 
locked filing cabinet in the clinic only accessible by the project coordinator, the nursing staff, 
and the Nurse Practitioner.  
 
An Electronic Medical Record (EMR) is an electronic version of the record of your care 
within a health system. An EMR is simply a computerized version of a paper medical 
record.  If you are receiving care or have received care at Sanford (outpatient or inpatient) 
and are participating in a Sanford study, results of related procedures (i.e. laboratory tests, 
imaging studies and clinical procedures) may be placed in your existing EMR maintained by 
Sanford.  The completed advance care plans will be placed into your EMR to be accessible 
by health care providers and staff during future office visits and hospitalizations.   
 
Is this study voluntary? 
Your participation is voluntary. You can choose not to participate or you may stop your 
participation at any time without penalty or loss of benefits to which you are otherwise 
entitled.  
 
Your decision whether or not to participate will not affect your current or future relations 
with Sanford Health.   
 
Who can I talk to? 
You may ask any questions you have now or later. 
 
If you have questions, concerns, or complaints, or think the study has hurt you, talk to the 
team at (605) 610-9039 or nephrologyacp@gmail.com 
For this study you must be 18 years of age older to consent to participate in this study. 
 
Your signature documents your permission to take part in this study. 
 
   
Signature of subject  Date 
 
 
Printed name of subject 
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Signature of person obtaining consent  Date 
 
Printed name of person obtaining consent 
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Appendix O: Project Procedure Algorithm 
 
Advance Care Planning Procedure 
Algorithm 
RN/LPN to print NP schedule each AM 
 
 
 
 
RN/LPN and NP determine which patients are eligible to receive the intervention (CKD 
stages four and five, GFR less than 30 mL/min/1.73 m2).  Place an asterisk on the printed 
schedule next to each who is eligible to receive the intervention.  Place printed schedule by 
the clinic receptionist. 
 
 
 
Clinic receptionist to give each eligible patient an informal letter of invitation at the time of 
registration 
 
 
 
While rooming the patient, RN/LPN collect informal letter of invitation from all patients with 
marked response (I agree to participate or I decline to participate).  If patient agrees to 
participate, RN will then ask patient if he or she has an advance directive document.  If 
patient does not, then give and collect informed consent form from patient.  Administer pre-
assessment knowledge test to patient after completing rooming activities.  Keep all forms in 
collected in locked filing cabinet. 
(Continue through care as usual if patient already has an advance directive.) 
 
 
 
RN/LPN report off to NP whether patient has an advance directive document.  NP to 
implement intervention using the five question tool if patient does not have an advance 
directive.  NP collect form from patient if completed during the clinic visit and give to 
RN/LPN.  Clinic manager to notarize document.  Copy completed document.  Scan to 
medical records.  Send copy to medical records.  Keep original in locked filing cabinet.  RN 
to administer post-assessment knowledge test to patient after the discussion.  Keep 
assessment documents in locked filing cabinet.  NP to document in clinic note regarding 
discussion. 
**(If intervention tool is returned at a later date, follow same instructions above for scanning 
to medical records.)** 
 
 
 
